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I. INTRODUCTION
A. Health Insurance Portability and Accountability Act of 1996
(''HIPAA''), 42 U.S.C. §§1320d - 1329d-8. How big is the
"hippopotamus"? Five (5) Titles long:
1. Title I, Health Care Access, Portability and
Renewability
2. Title II, Preventing Fraud and Abuse and
Administrative Simplification (the latter of which
could be claimed a .misnomer)
(A) Subtitle F is the "Administrative
Simplification" portion of the Act.
(B) "Administrative Simplification"
provisions exist for 3 reasons:
(1) "to protect and
enhance the rights of
consumers by
providing them access
to their health
information and
controlling the
inappropriate use of
that information;"
(2) to improve the quality
of care "by restoring
A-I
trust in the system"
among consumers,
providers and others
involved in health care
delivery;
(3) "to improve the
efficiency and
effectiveness of health
care delivery by
creating a national
framework for health
privacy protection."
65 Fed. Reg. 82642,
82643 (12/28/00).
(C) HIP A A's Adm i n i s t rat i v e
Simplification directive is to reduce
costs in the health care system by
standardizing electronic health care
transactions. 42 U.S.C. §1320d-l(b).
(D) With increased electronic transmission
of confidential health information,
Congress perceived the need to act to
protect against the potential of
disclosure of private information.
HIP AA' s Administrative
Simplification provisions are intended
to address these concerns by providing
standards.
(1) E.g., Administrative
Simplification requires
the establishment of
privacy stalldards; and
(2) Adm i n i s t rat i v e
Simplification also
requires the
establishment of
security standards,
among other standards.
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(E) Status of HIPAA's various
components in the promulgation of
rules and regulations:
(1) Standards for
electronic transactions:
final regulations issued
8/17/00 (45 C.F.R.
Parts 160 and 162).
(2) National standard
health care provider
identifier: proposed
regulations, subject to
public comment,
published 5/7/98 (63
Fed. Reg. 25320).
(3) National standard
employer identifier:
proposed regulations,
subject to public
comment, published
6/16/98 (63 Fed. Reg.
32784).
(4) Security and electronic
signature standards:
proposed rules, subject
to public comment,
published 8/12/98 (63
Fed. Reg. 43242).
(5) Standards for privacy
of individually
identifiable
information: final
regulations issued
12/20/00, and effective
4/14/01(45 C.F.R.
Parts 160 & 164).
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(6) National Health Plan
Identifiers: no
regulations yet.
(7) Enforcement: no
regulations proposed
yet.
(8) Claims Attachments:
no regulations
proposed yet.
(9) National Individual
Identifiers: no
regulations proposed
yet.
3. Title III, Tax-Related Provisions
4. Title IV, Application and Enforcement of Group
Health Plan Requirements, and
5. Title V, Revenue Offsets.
B. Administrative Simplification - HIPAA's New Privacy Rules For
Patient Health Information: An Overview of HIPAA Privacy Rule
Compliance
1. The Final Rules Setting Standards for Privacy of
Individually Identifiable Health Information provide
the frrst comprehensive federal law basis for the
protection of privacy and confidentiality of patient
health information.
2. The Proposed and Final Rules under HIPAA's
Administrative Simplification provisions are primarily
concerned with STANDARDS. Standards under
HIPAA's Privacy Rule are concerned with
safeguarding medical information and providing
boundaries for the use of medical information, with
accountability for non-compliance.
c. Why do we need HIPAA?
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Current law allows the use and transmission ofpatient identifiable health information
for nonmedical purposes. The information can and is used frequently by marketers,
lenders, and employers, without patient consent. One study indicated that as many
as 35% of Fortune 500 companies evaluate the medical records of their employees
prior to making hiring, firing, and promotion decisions. l
D. Who does HIPAA regulate?
The final rule applies to Health Plans, health care clearinghouses (such as those
which translate or process patient treatment data and codes), and those health care
providers who conduct certain financial and administrative transactions, such as
electronic billing and fund transfers.
E. What Infoffilation is regulated?
All patient medical records, along with any other patient identifiable data that is used
or transmitted by a covered entity, regardless of whether transmission occurs
electronically, orally, or on paper. The regulated information includes patient billing
records, demographic information, and other administrative data that is identified by
individual patient.
F. When do I have to comply with HIPAA?
Most health care providers have until April 14, 2003 to fully comply with the HIPAA
privacy rules. Small health plans have until April 14, 2004 to comply.
II. How will HIPAA Change my Health Care Practice?
A. The Basic Privacy Requirements of HIPAA
1. HIPAA requires that health care providers obtain patient consent for
disclosures of individual health information for purposes of treatlnent,
payment, and other health care operations.2
2. In addition to consent, patients must receive notice of the provider's
privacy policies, in a form that is distinct from the consent form. This
1 See Paul Starr, "Health and the Right to Privacy," American Journal of Law and Medicine, Vol. 25,
pp. 193-201 (1999).
2 An entity covered by HIPAA "may not use or disclose an individual's protected health information
["PHI"] except as otherwise permitted or required by this subpart..." 45 Code of Federal Regulations
164.502(a).
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notice must explain how the patient's information will be used and the
ways in which it will be protected.
3. Permitted Uses and Disclosures Made with Patient Consent Include:
a. Those made to the individual patient who is the subject of the
information;
b. Those made with the consent of the patient for purposes of
treatment, payment, and health care operations;
c. Disclosures made for purposes not related to health care, when
the patient has given the provider specific authorization for such
use.
4. Permitted Uses and Disclosures made without Patient Consent include:
a. Those made in limited cases, such as emergencies, for purposes
of treatment, payment, and health care operations;
b. Disclosures made without the individual's consent, and when the
patient has not affirmatively objected, but has the opportunity to
either agree or object prior to disclosure (such as when a provider
believes that the patient's family members or caregivers should
receive the information);
c. Those made without consent, when those disclosures are to
government agellcies for purposes of ensuring compliance with
regulatory standards;
d. Disclosures made in the course of treatment when the provider is
legally required to treat the individual;
e. Disclosures made for purposes of law enforcement (such as
pursuant to a subpoena), and that only give the minimum
information necessary for enforcement purposes;
f. Disclosures made to ensure the health and safety of the public,
when the provider is reasonably certain that 1) a patient poses an
imminent threat to the public, and 2) the person to whom the
information is being disclosed can effectively avert or prevent
such threatened danger from occurring;
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g. Those made when the provider attempted to obtain consent, but
was prevented from doing so due to substantial communication
barriers with the patient. In such cases, the provider must believe
that consent can be inferred from the circumstances;
h. Disclosures made for purposes such as research, as long as the
patient data has been de-identified so that it cannot be traced to
the individual;
I. Disclosures to public health officials for purposes of preventing
or controlling disease, injury, or maintaining birth or death
statistics; and
j. Uses and disclosures made when the provider has an indirect
treatment relationship with the patient, such as whell the provider
is a laboratory technician or a pathologist. No consent is required
in this situation because it is assumed that the patient's primary
provider has obtained consent for the use of the information for
health care purposes.
B. "Minimum Information Required" Standard
1. Disclosures must be made with the minimum information necessary to
accomplish the intended purpose.
2. Requires that providers use their professional judglnent and make
reasonable efforts to determine the minimum amount of information that
can be disclosed.
3. Does not apply to disclosures made to another health care provider for
treatment purposes, or requests for patient information made by another
health care provider for treatment purposes.
4. Does apply to all disclosures made for purposes of payment, billing, and
other administrative health care operations.
5. Does not apply to requests by the individual for his or her own
information, or to disclosures to HIPAA enforcement officials.
6. Requires that covered entities develop protocols, procedures, and
standards for determining what information is necessary for disclosure,
and that they restrict access to use of patient information based on the
specific roles of the provider's workforce.
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a. Physicians or specialists typically may' be given access to the
entire medical record;
b. Nurses or other providers might only have access while they are
on duty providing care for the individual patient.
7. Allows disclosure of the entire medical record only when there is explicit
justification for such wide disclosure by the requesting entity.
c. Special Rules for Marketing or FundraisingPurposes
1. Providers may use personal health information without patient
authorization under very narrow circumstances:
a. When the marketing is done under the specific name of the
provider, and when fundraising is for the provider's own benefit,
as long as the materials identify that the provider is the source of
the marketing, and state whether the provider is receiving
compensation from a third party (such as a drug manufacturer) for
the marketing.
b. Whet1 the marketing occurs during a face-to-face encounter with
the patient for health treatment purposes, such as during a
consultation or appointment (including instances in which a
provider might suggest that a patient try a certain drug or other
specifically named health care product).
c. When the marketing involves products or services of nominal
value, such as pens, notepads, or infant formula samples for new
or expectant mothers.
d. Fundraising material can only include demographic information
and the dates treatment was provided.
2. In all of the foregoing marketing scenarios, the patient must be given the
opportunity to "opt out" of receiving future marketing material or
promotional items.
D. Important Differences Between Consent, Notice, and Authorization
All providers with direct treatment relationships with patients are responsible for
implementing procedures for obtaining patient consent, for offering access to
Notice provisions, and obtau1ing Authorizations whet1 necessary:
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1. A Consent document generally gives health care providers who have a
direct treatment relationship with the patient permission to use and
disclose patient health information for purposes of providing treatment.
The Consent must refer to the Notice Document, and specify that the
patient has the right to review the entity's privacy practices prior to
signing the consent. HIPAA does not require that the individual either
read the Notice, or that the entity explain each element of the Notice prior
to the time the patient gives Consent. The patient must simply be
informed in the Consent that he or she has the right to review the Notice
if desired.
2. The Notice document must include a statement of the permitted uses of
patient information, the individual's rights, and the entity's legal
obligations with regard to ensuring the privacy of the information. The
Notice must prominently incorporate the statement, "This notice
describes how medical information about you may be used and disclosed
and how you can get access to this information. Please read it carefully."
45 CFR 164.520(b)(1)(i). The Notice must be provided to each patient
individually, and also must be posted in the provider's office. Unlike the
Consent doculnent, the Notice document only needs to be provided to
patients upon their request.
3. Covered entities must obtain Authorizations for all uses and disclosures
of patient information that are not for purposes of payment, treatment, or
healthcare operations. This Authorization document must be obtained
separate from and in addition to the Consent document. Purposes for
which an authorization must be obtained include research and release of
patient names for marketing purposes that are not otherwise allowed
under the HIPAA rules.
E. Psychotherapy Notes
Psychotherapy Notes are subject to a heightened degree of privacy protection
under HIPAA. For disclosure or use of such notes, a covered entity must obtain
patient authorization for any disclosure that is not for the purpose of treatment by
the mental health provider. Such provider may also deny the individual patient
access to their own records if, in the professional judgment of the mental health
provider, allowing the patient access will be detrimental to the patient. Patient
authorization does not have to be obtained from the individual if the provider
needs the information for defense of a legal action against the provider brought
by the patient.
F. The "Business Associates" Rule
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1. A Business Associate is defined under HIPAA as anyone who performs
services for a covered entity that involves the use or disclosure of patient
information. Examples of Business Associates include lawyers,
accountants, billing administrators, and accrediting bodies.
2. Covered entities must do two things when dealing with Business
Associates:
a. Enter into a written contract containing satisfactory assurances
that the business associate will safeguard any patient health
information it receives from the covered entity. The contract must
require the business associate to 1) comply with the terms of the
contract for protection of patient health .information, and 2)
initiate appropriate internal procedures and practices to ensure
such compliance.
b. The terms of the written contract must provide that the
relationship between the covered entity and the business associate
may be terminated if the covered entity concludes that the
business associate has violated the privacy requirements of the
contract. Covered entities must then take steps to remedy the
violation by the business associate when possible.
3. As long as the disclosure is for treatment purposes, a covered entity is
NOT required to enter into a business associate contract with the recipient
of the patient information. Treatment is defined under HIPAA as the
provision of health care services to an individual by one or more
providers, coordination of treatment between providers, and patient
referrals for health care services.
G. Securing Patient Records and Health Information
1. HIPAA requires that health care providers design their own plan for
securing patient records. The standard is flexible and is intended to allow
providers to create and implement a plan that is reasonable for their
practice. The requirements allow providers to design compliance
programs that are appropriate for the size and scope of their organization.
Specific requirements for securing patient information include:
a. Adopt Written Procedures: Covered entities must develop written
polices for designating how patient information will be used
within their organization, who will have access to that
information, and how and·. when the information may be
disclosed.
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b. Train Employees: Providers must ensure that their employees
have been appropriately trained regarding HIPAA privacy rules
and compliance procedures. All covered entities must designate
an employee who will be responsible for implementing and
maintaining HIPAA compliance for the organization.
c. Limit Employee Access to Patient Records: Providers must make
reasonable efforts to limit access to patient information to their
employees based on the roles those employees play within the
organization. This may include:
1. Configuring computer data systems in a way that only
allows certain employees access to patient information.
Providers should develop a password system that allows
employees access to no more of the patient's information
than is necessary for performance of their job duties.
ii. Securing Patient paper files in an isolated area, out of the
view of other patients, and placing all patient files in
cabinets that may be locked.
iii. Conduct oral communications with patients in rooms or
areas that allow as much ptivacy as is reasonable for the
practitioner. In taking into consideration whether a
provider has complied with HIPAA, the Department of
Health and Human Services will evaluate all
circumstances unique to the provider, including the effect
increased privacy protection would have on the quality of
care provided.
2. HIPAA does not require that providers physically restructure their work
environments, retrofit patient consultation areas, or overhaul computer
systems. Instead, the privacy rules are intended to make providers
evaluate their organization and implement reasonable safeguards based
on the particularities of their organization.
III. Enforcement of HIPAA
A. HIPAA provides civil and criminal penalties for covered entities that improperly
disclose patient health information. If a patient or any other individual believes
that health information has been improperly used or disclosed, then they may file
a complaint with the Office of Civil Rights ("OCR") of the Department for
Health and Human Services ("DHHS"). DHHS Inay then initiate an investigation
that may encompass the provider's entire compliance program, in addition to the
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circumstances surrounding the Complaint. If such an investigation is initiated,
then the provider is required to allow DHHS access to its facilities, books,
accounts, and patient information. If DHHS determines that the potential
violation is extreme enough, they have the right to gain access to the provider's
facility and records at any time and without notice to the provider. 45 CFR
160.310.
B. Civil Monetary Penalties: DHHS has authority to assign providers with monetary
penalties up to $100 per violation, and up to $25,000 per year.
c. Criminal Penalties: HIPAA provides for criminal penalties of up to $50,000
and/or imprisonment for up to one year for an entity that knowingly and
intentionally violates a privacy rule. The penalty increases to $100,000 and/or
imprisonment for up to five years for violations under false pretenses, and
increases further to a limit of $250,000 and/or imprisonment for up to ten years
for any provider who discloses or uses patient health information with the intent
to sell, transfer, or otherwise use the infonnation for commercial gain.
IV. Guidelines for Implementing a HIPAA Compliance Program
A. Knowledge: Develop a working knowledge of HIPAA requirements and how
they will affect your practice. Understanding the regulations and knowing what
they do require, as well as what they don't require, is the most important factor
in initiating HIPAA compliance.
B. Risk Assessment: Conduct an internal risk assessment to evaluate your current
health care records and patient information practices. Develop a list of problem
areas, and start thinking now about how those problems can be remedied.
C. Identify Resources: There are many Guidance and publications generated by
DHHS that are intended to ease the transition into HIPAA compliance. An
excellent Guidance in the form of frequently asked questions may be found at
http://aspe.os.dhhs.gov/admnsimp/finallpvcguide1.htrn. The OCR website offers
a mailing list for those who wish to kept informed about developments in the
proposed amendments to HIPAA. There are also many computer software
programs designed for facilitation of HIPAA compliance.
D. Get Professional Help: Hire a health care lawyer to either assist you in putting
together a compliance program, or review the program you evelltually
implement. Since many of HIPAA' s exceptions to the disclosure rules are
dependent on the individual facts of the case, the aid of counsel will be
instrumental in a good outcome.
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E. Name Your Leader: Each covered entity is required to designate an employee
who will be responsible for implementing and maintaining HIPAA compliance.
The sooner you identify that person, the sooner your organization can integrate
patient information practices that facilitate HIPAA Compliance.
A-13
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I. Consents (45 C.F.R. § 164.506)
A. General Rule
Under the Privacy Rule, healthcare providers with a "direct treatment
relationship" must obtain a consent from patients to "use" (internal) or
"disclose" (to outside persons/entities) protected health information
("PHI") for:
1. treatment (e.g., consultations between healthcare providers relating
to a patient or the referral of a patient);
2. payment (e.g., obtaining reimbursement for the provision of health
care); or
3. health care operations (i.e., quality assessment and improvement,
case management, care coordination and peer review).
Health plans and health care clearinghouses, the other covered entities
under the Privacy Rule, may use and disclose PHI for treatment, payment
or health care operations ("TPO") without obtaining a consent. They may
choose to obtain consents if they wish, but consents must meet the
standards for a consent under 45 C.F.R. § 164.506.
B. Exceptions
1. There is an indirect treatment relationship with the patient. An
"indirect treatment relationship" exists when a provider delivers
health care to the patient based upon the orders of another provider
and typically reports to the originating provider. Examples: x-
rays, lab work.
2. The provider created or received the PHI in the course of providing
health care to an inmate.
Note: In the following three situations, if consent is not obtained, the
provider must document the attempt to obtain consent and the reason why
consent was not obtained.
3. In emergency treatment situations, if the provider attempts to
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obtain consent as soon as reasonably practicable after the delivery
of treatment.
4. If the provider is required by law to treat the patient, and attempts
to but is unable to obtain consent.
5. If a provider attempts but is unable to obtain consent due to
substantial barriers to communicating with the patient, and the'
provider determines, in the exercise of professional judgment, that
the patient's consent to treatment can be clearly inferred from the
circumstances.
c. May's, Shall's and Shan't's
1. May's
a. A provider may condition treatment on the provision by the
patient of a consent.
b. A health plan may condition enrollment on the provision by
an individual of a consent sought in conjunction with
enrollment.
c. A consent for may be combined with other types of written
legal permission from the individual (e.g., an informed
consent for treatment or a consent to assignment of
benefits) if the consent is visually and organizationally
separate from such other written legal permission and is
separately signed and dated.
d. A consent for use or disclosure may be combined with a
research authorization under 45 C.F.R. § 164.508(t), as
long as the two are visually and organizationally separate
and are separately signed and dated.
2. Shall's
a. A covered entity must document and retain any signed
consent as required by 45 C.F.R. § 164.5300), i.e., six years
from the date of its creation or the date it was last in effect,
whichever is later.
3. Shan't's
a. Consents obtained by one provider are not effective and
cannot be used to permit another provider or covered entity
to use or disclose the PHI to which the consent form relates.
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D. So what does a consent have to look like?
1. Must be in plain language;
2. Be visually and organizationally separate from other written legal
permission;
3. Be separately signed and dated by the individual;
4. Inform the individual that PHI may be used and disclosed to carry
out treatment, payment, or health care operations;
5. Refer the individual to the notice he or she is entitled to under 45
C.F.R. §164.520 for a more complete description of uses and
disclosures and state that the individual has the right to review the
notice prior to signing the consent;
6. If the covered entity has reserved the right to change its privacy
practices that are described in the notice given to the individual,
state that the terms of the privacy notice may change and describe
how the individual may obtain a revised notice;
7. State that the individual has the right to request that the covered
entity restrict how PHI is used or disclosed to carry out treatment,
payment or health care operations;
8. State that the covered entity is not required to agree to requested
restrictions by the individual but that, if it does, the agreed-to
requested restrictions are binding on the covered entity;
9. State that the individual has the right to revoke the consent in
writing, except to the extent that the Covered Entity has taken
action in reliance on it.
II. Authorizations (45 C.F.R. § 164.508)
A. DistinctioII Between Consents aIld l\uthorizations
The Department of Health and Human Services Office for Civil Rights, which is
in charge of enforcing the Privacy Rule, issued a guidance paper on the
Privacy Rule on July 6,2001. The guidance paper may be found at
http://aspe.hhs.gov/admnsimp/finallpvcguideI.htm. It contained the
following explanation of the difference between a consent and an
authorization:
A consent is a general document that gives health care
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providers, which have a direct treatment relationship with a
patient, permission to use and disclose all PHI for TPO. It
gives permission only to that provider, not to any other
person. Health care providers may condition the provision of
treatment on the individual providing this consent. One
consent may cover all uses and disclosures for TPO by that
provider, indefinitely. A consent need not specify the
particular information to be used or disclosed, nor the
recipients of disclosed information.
Only doctors or other health care providers with a direct
treatment relationship with a patient are required to obtain
consent. Generally, a "direct treatment provider" is one that
treats a patient directly, rather than based on the orders of
another provider, and/or provides health care services or test
results directly to patients. Other health care providers,
health plans, and health care clearinghouses may use or
disclose information for TPO without consent, or may
choose to obtain a consent.
An authorization is a more customized document that gives
covered entities permission to use specified PHI for
specified purposes, which are generally other than TPO, or
to disclose PHI to a third party specified by the individual.
Covered entities may not condition treatment or coverage on
the individual providing an authorization. An authorization
is more detailed and specific than a consent. It covers only
the uses and disclosures and only the PHI stipulated in the .
authorization; it has an expiration date; and, in some cases,
it also states the purpose for which the information may be
used or disclosed.
An authorization is required for use and disclosure of PHI
not otherwise allowed by the rule. In general, this means an
authorization is required for purposes that are not part of
TPO and not described in § 164.510 (uses and disclosures
that require an opportunity for the individual to agree or to
object) or § 164.512 (uses and disclosures for which
consent, authorization, or an opportunity to agree or to
object is not required)....
All covered entities, not just direct treatment providers, must
obtain an authorization to use or disclose PHI for these
purposes. For example, a covered entity would need an
authorization from individuals to sell a patient mailing list,
to disclose information to an employer for employment
decisions, or to disclose information for eligibility for life
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insurance. A covered entity will never need to obtain both an
individual's consent and authorization for a single use or
disclosure. However, a provider may have to obtain consent
and authorization from the same patient for different uses or
disclosures. For example, an obstetrician may, under the
consent obtained from the patient, send an appointment
reminder to the patient, but would need authorization from
the patient to send her name and address to a company
marketing a diaper service.
B. Valid Authorizations Must Contain:
1. A description of the information to be used or disclosed that
specifically and meaningfully identifies the information;
2. The name or other specific identification of the person(s), or class
of persons, authorized to make the requested use or disclosure;
3. The name or other specific identification of the person(s), or class
of persons, to whom the covered entity may make the requested use
or disclosure;
4. An expiration date or event that relates to the individual or the
purpose of the use or disclosure;
5. A statement of the individual's right to revoke the authorization in
writing and the exceptions of the right to revoke, together with a
description of how to revoke the authorization;
6. A statement that the information used or disclosed pursuant to the
authorization may be subject to redisclosure by the recipient and no
longer be protected by this rule;
7. Signature of the individual and the date;
8. If the authorization is signed by a personal representative of the
individual, a description of such representative's authority to act for
the individual; and
9. The authorization must be written in plain language.
C. Additional Requirements for Authorizations Requested by a Covered
Entity for Its Own Uses and Disclosures
If an authorization is requested by a covered entity for its own use or
disclosure of PHI that it maintains, the covered entity's authorization must
comply with the following:
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I. requirements II.B.I-9 above for a valid authorization;
2. a statement that the covered entity will not condition treatment,
payment, enrollment in a health plan, or eligibility for benefits on
the individual's agreement to authorize the requested use or
disclosure, but only if the authorization is one to which 45 C.F.R.
164.508(b)(4)'s prohibition on conditioning applies;
3. a description of each purpose of the requested use or disclosure;
4. a statement that the individual may:
a. inspect or copy the PHI to be used or disclosed as provided
in 45 C.F.R. § 164.524; and
b. refuse to sign the authorization;
5. if use or disclosure of the requested information will result in direct
or indirect remuneration to the covered entity from a third party, a
statement that such remuneration will result; and
6. the covered entity must provide the individual with a copy of the
signed authorization.
D. Additional Requirements for Authorizations Requested by a Covered
Entity for Disclosures by Others
If an authorization is requested by a covered entity for another covered
entity to disclose PHI to the covered entity requesting the authorization to
carry out TPO, the covered entity requesting the authorization must
comply with the following requirements:
I. requirements II.B.I-9 above for a valid authorization;
2. a description of each purpose of the requested use or disclosure;
3. except for an authorization on which payment may be conditioned
under 45 C.F.R. § 164.508(b)(4)(iii), a statement that the covered
entity will not condition treatment, payment, enrollment in a health
plan, or eligibility for benefits on the individual's providing
authorization for the requested use or disclosure;
4. a statement that the individual may refuse to sign the authorization;
and
5. the covered entity must provide the individual with a copy of the
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signed authorization.
E. Additional Requirements for Authorizations for Uses and Disclosures
of pm Created for Research That Includes Treatment of the
Individual.
Except as otherwise permitted by 45 C.F.R. § 164.512(i), a covered entity
that creates PHI for the purpose, in whole or in part, of research that
includes treatment of individuals must obtain an authorization for the use
or disclosure of such information. Such authorization must:
1. for uses and disclosures not otherwise permitted or required under
Subpart E of the Privacy Rule, meet the requirements of II.B. and
II.C;
2. contain a description of the extent to which such PHI will be used
or disclosed to carry out TPO;
3. contain a description of any PHI that will not be used or disclosed
for purposes permitted in accordance with 45 C.F.R. §§ 164.510
and 164.512, provided that the covered entity may not include a
limitation affecting its right to make a use or disclosure required by
law or permitted by 45 C.F.R. § 164.512(j)(1)(i); and
4. if the covered entity has obtained or intends to obtain the
individual's consent under 45 C.F.R. § 164.506, or has provided or
intends to provide the individual with a notice under 45 C.F.R. §
164.520, the authorization must refer to that consent or notice, as
applicable, and state that the statements made pursuant to 45
C.F.R. § 164.508 are binding.
This type of authorization may be in the same document as a consent to
participate in the research, a consent to use or disclose PHI to carry out
TPO, or a notice of privacy practices.
F. Authorizations Required for Psychotherapy Notes
Notwithstanding any other provisions of subpart E of the Privacy Rule
other than the transition provisions in 45 C.F.R. § 164.532, a covered
entity must obtain an authorization for any use or disclosure of
psychotherapy notes, except:
1. To carry out the following TPO consistent with the consent
requirements of 45 C.F.R. § 164.506:
a. use by the originator of psychotherapy notes for treatment;
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b. use or disclosure by the covered entity in training programs
in which students, trainees, or practitioners in mental health
learn under supervision to practice or improve their skills in
group, joint, family, or individual counseling; or
c. use or disclosure by the covered entity to defend a legal
action or other proceeding brought by the individual; and
2. A use or disclosure that is required by 45 C.F.R. § 164.502(a)(2)
(ii) or permitted by 45 C.F.R. § 164.512(a); 45 C.F.R. § 164.512(d)
with respect to the oversight of the originator of the psychotherapy
notes; 45 C.F.R. § 164.512(g)(I); or 45 C.F.R. § 164.512(j)(I)(i).
Note that this provision means that a provider would need to obtain
authorization and not consent to use or disclose PHI maintained in
psychotherapy notes for treatment by persons other than the originator of
the notes, for payment, or for health care operations purposes, except as
specified in the Privacy Rule (§ 164.508(a)(2)).
G. Resolving Conflicting Consents and Authorizations
1. If a covered entity has obtained a consent under 45 C.F.R. §
164.506 and receives any other authorization or writte~ legal
permission from the individual for a disclosure of PHI to carry out
TPO, the covered entity may disclose such PHI only in accordance
with the more restrictive consent, authorization, or other written
legal permission from the individual.
2. A covered entity may attempt to resolve a conflict between a
consent and an authorization or other written legal permission from
the individual described in paragraph 1 of this section by:
a. Obtaining a new consent from the individual under 45
C.F.R. § 164.506 for the disclosure to carry out TPO; or
b. Communicating orally or in writing with the individual in
order to determine the individual's preference in resolving
the conflict. The covered entity must document the
individual's preference and may only disclose PHI in
accordance with the individual's preference.
H. Compound Authorizations
An authorization may not be combined with any other document to create
a compound authorization, except as follows:
1. An authorization for the use or disclosure of PHI created for
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research that includes treatment of the individual may be combined
as permitted by 45 C.F.R. § 164.506(b)(4)(ii) or 45 C.F.R. §
164.508(0;
2. An authorization for the use or disclosure of psychotherapy notes
may only be combined with another authorization for a use or
disclosure of psychotherapy notes;
3. An authorization, other than an authorization for the use or
disclosure of psychotherapy notes, may be combined with any
other authorization, except when a covered entity has conditioned
the provision of treatment, payment, enrollment in the health plan,
or eligibility for benefits under § 164.508(b)(4) on· the provision of
one of the authorizations.
I. Prohibition on Conditioning of Authorizations
A covered entity may not condition the provision to an individual of
treatment, payment, enrollment in the health plan, or eligibility for benefits
on the provision of an authorization, except:
1. A provider may condition the provision of research-related
treatment on the provision of an authorization under 45 C.F.R. §
164.508(0;
2. A health plan may condition enrollment in the health plan or
eligibility for benefits on provision of an authorization requested
by the health plan prior to an individual's enrollment in the health
plan, if:
a. the authorization sought is for the health plan's eligibility or
enrollment determinations relating to the individual or for
its underwriting or risk rating determinations; and
b. the authorization is not for a use or disclosure of
psychotherapy notes;
3. A health plan may condition payment of a claim for specified
benefits on provision of an authorization under 45 C.F.R. §
164.508(e) if:
a. the disclosure is necessary to determine payment of such
claim; and
b. the authorization is not for a use or disclosure of
psychotherapy notes; and
4. A covered entity may condition the provision of health care that is
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solely for the purpose of creating PHI for disclosure to a third party
on provision of an authorization for the disclosure of the PHI to the
third party.
J. Revoking Authorizations
An individual may revoke an authorization at any time, provided that the
revocation is in writing, except to the extent that:
1. the covered entity has taken action in reliance on it; or
2. if the authorization was obtained as a condition of obtaining
insurance coverage, other law provides the insurer with the right to
contest a claim under the policy.
K. Retention of Authorizations
A covered entity must document and retain any signed authorization as
required by 45 C.F.R. § 164.530G), i.e., six years from the date of its
creation or the date it was last in effect, whichever is later.
L. Uses and Disclosures Requiring an Opportunity for the Individual to
Agree or Object (45 C.F.R. § 164.510)
A covered entity may use or disclose PHI without the written consent or
authorization of the individual provided that the individual is informed in
advance of the use or disclosure and has the opportunity to agree to or
prohibit or restrict the disclosure in accordance with the applicable
requirements of 45 C.F.R. § 164.510. The covered entity may orally
inform the individual of and obtain the individual's oral agreement or
objection to a use or disclosure permitted by 45 C.F.R. § 164.510.
1. Facility Directories
a. Except when an objection is expressed, a provider may use
the following PHI to maintain a directory of individuals in
its facility:
1. the individual's name;
11. the individual's location in the facility;
iii. the individual's condition described in general terms
that does not communicate specific medical
information about the individual; and
iv. the individual's religious affiliation.
b. Except when an objection is expressed, the provider may
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disclose for directory purposes the information in (a) above
to:
1. members of the clergy; or
ii. except for religious affiliation, to other persons who
ask for the individual by name.
c. A provider must inform an individual of the PHI it may
include in a directory and the persons to whom it may
disclose such PHI and provide the individual with the
opportunity to restrict or prohibit some or all of the uses or
disclosures permitted by (a) and (b) above. If the
opportunity to object cannot practicably be provided
because of the individual's incapacity or an emergency
treatment situation, a provider may use or disclose some or
all of the PHI permitted by (a) above, if such disclosure is:
1. consistent with a prior expressed preference of the
individual, if any, that is known to the provider; and
11. in the individual's best interest as determined by the
provider in the exercise of professional judgment.
The provider must inform the individual of the uses and
disclosures made during the individual's incapacity or an
emergency treatment situation when it becomes practicable
to do so and must give the individual an opportunity to
object to further uses or disclosures for directory purposes
at that time.
2. Uses and Disclosures for Involvement in the Individual's Care
and Notification Purposes.
a. A covered entity may disclose to a family member, other
relative, or a close personal friend of the individual, or any
other person identified by the individual, the PHI directly
relevant to such person's involvement with the individual's
care or payment related to the individual's health care.
b. A covered entity may use or disclose PHI to notify, or assist
in the notification of (including identifying or locating), a
family member, a personal representative of the individual,
or another person responsible for the care of the individual
of the individual's location, general condition, or death.
Any such use or disclosure of PHI for such notification
purposes must be in accordance with paragraphs (c), (d), or
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(e) below, as applicable.
c. If the individual is present for, or otherwise available prior
to, a use or disclosure permitted by paragraph (a) or (b)
above and has the capacity to make health care decisions,
the covered entity may use or disclose the PHI if it:
i. Obtains the individual's agreement;
11. Provides the individual with the opportunity to
object to the disclosure, and the individual does not
express an objection; or
iii. Reasonably infers from the circumstances, based the
exercise of professional judgment, that the
individual does not object to the disclosure.
d. If the individual is not present, or the opportunity to agree
or object to the use or disclosure cannot practicably be
provided because of the individual's incapacity or an
emergency circumstance, the covered entity may, in the
exercise of professional judgment, determine whether the
disclosure is in the best interests of the individual and, if so,
disclose only the PHI that is directly relevant to the
person's involvement with the individual's health care. A
covered entity may use professional judgment and its
experience with common practice to make reasonable
inferences of the individual's best interest in allowing a
person to act on behalf of the individual to pick up filled
prescriptions, medical supplies, X-rays, or other similar
forms of PHI.
e. A covered entity may use or disclose PHI to a public or
private entity authorized by law or by its charter to assist in
disaster relief efforts, for the purpose of coordinating with
such entities the uses or disclosures permitted by paragraph
(b) above. The requirements in paragraphs (c) and (d)
above apply to such uses and disclosures to the extent that
the covered entity, in the exercise of professional judgment,
determines that the requirements do not interfere with the
ability to respond to the emergency circumstances.
M. Uses and Disclosures for which Consent, an Authorization, or
Opportunity for the Individual to Agree or Object Is Not Required
(45 C.F.R. § 164.512)
Note: This section does not explore this particular regulation in depth, as
parts of it will be addressed by other speakers. This section consumes 6
pages of the Federal Register; therefore, please consult the regulation for
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detailed requirements concerning the listed exceptions.
1. Uses and disclosures required by law
2. Uses and disclosures for public health activities
3. Disclosures about victims of abuse, neglect, or domestic violence
4. Uses and disclosures for health oversight activities
5. Disclosures for judicial and administrative proceedings
6. Disclosures for law enforcement purposes
7. Uses and disclosures about decedents
8. Uses and disclosures for cadaveric organ, eye, or tissue donation
purposes
9. Uses and disclosures for research purposes
10. Uses and disclosures to avert a serious threat to health or safety
11. Uses and disclosures for specialized government functions
12. Disclosures for workers' compensation
N. Transition Provisions (Prior Consents and Authorizations - 45 C.F.R.
§ 164.532)
1. Effect of prior consents and authorizations.
A covered entity may continue to use or disclose PHI pursuant to a
consent, authorization, or other express legal permission obtained
from an individual permitting the use or disclosure of PHI that
does not comply with 45 C.F.R. §§ 164.506 or 164.508 consistent
with paragraph 2 of this section.
2. Requirements for retaining effectiveness of prior consents and
authorizations.
The following provisions apply to use or disclosure by a covered
entity of PHI pursuant to a consent, authorization, or other express
legal permission obtained from an individual permitting the use or
disclosure of PHI, if the consent, authorization, or other express
legal permission was obtained from an individual before the
applicable compliance date of the Privacy Rule and does not
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comply with 45 C.F.R. §§ 164.506 or 164.508.
a. If the consent, authorization, or other express legal
permission obtained from an individual permits a use or
disclosure for purposes of carrying out TPO, the covered
entity may, with respect to PHI that it created or received
before the applicable compliance date of the Privacy Rule
and to which the consent, authorization, or other express
legal permission obtained from an individual applies, use or
disclose such information for purposes of carrying out
TPO, provided that:
1. The covered entity does may not make any use or
disclosure that is expressly excluded from the a
consent, authorization, or other express legal
permission obtained from an individual; and
ii. The covered entity complies with all limitations
placed by the consent, authorization, or other
express legal permission obtained from an
individual.
b. If the consent, authorization, or other express legal
permission obtained from an individual specifically permits
a use or disclosure for a purpose other than to carry out
TPO, the covered entity may, with respect to PHI that it
created or received before the applicable compliance date
of the Privacy Rule and to which the consent, authorization,
or other express legal permission obtained from an
individual applies, make such use or disclosure, provided
that:
i. The covered entity does not make any use or
disclosure that is expressly excluded from the
consent, authorization, or other express legal
permission obtained from an individual; and
ii. The covered entity complies with all limitations
placed by the consent, authorization, or other
express legal permission obtained from an
individual.
c. In the case of a consent, authorization, or other express
legal permission obtained from an individual that identifies
a specific research project that includes treatment of
individuals:
1. If the consent, authorization, or other express legal
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permission obtained from an individual specifically
permits a use or disclosure for purposes of the
project, the covered entity may, with respect to PHI
that it created or received either before or after the
applicable compliance date of the Privacy Rule and
to which the consent or authorization applies, make
such use or disclosure for purposes of that project,
provided that the covered entity complies with all
limitations placed by the consent, authorization, or
other express legal permission obtained from an
individual.
ii. If the consent, authorization, or other express legal
permission obtained from an individual is a general
consent to participate in the project, and a covered
entity is conducting or participating in the research,
such covered entity may, with respect to PHI that it
created or received as part of the project before or
after the applicable compliance date of the Privacy
Rule, make a use or disclosure for purposes of that
project, provided that the covered entity complies
with all limitations placed by the consent,
authorization, or other express legal permission
obtained from an individual.
d. If, after the applicable compliance date of the Privacy Rule,
a covered entity agrees to a restriction requested by an
individual under 45 C.F.R. § 164.522(a), a subsequent use
or disclosure of PHI that is subject to the restriction based
on a consent, authorization, or other express legal
permission obtained from an individual as given effect by
this section, must comply with such restriction.
.1.11. .Not.ices (45 C.F.R. § 164.520)
i\. Relationsllip llet\VeCll Consents and Notices
When asked t() explain tile interrelationship bet\veen consellts anti notices,
the Department of Health and Human Services Office for Civil Rights,
which is in charge of enforcing the Privacy Rule, answered as follows in a
guidance paper on the Privacy Rule on July 6, 2001:
The consent and the notice of privacy practices are two
distinct documents. A consent document is brief (may be
less than one page). It must refer to the notice and must
inform the individual that he [or she] has the opportunity to
review the notice prior to signing the consent. The Privacy
Rule does not require that the individual read the notice or
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that the covered entity explain each item in the notice before
the individual provides consent. We expect that some
patients will simply sign the consent while others will read
the notice carefully and discuss some of the practices with
the covered entity.
.B. Rigllt tf.l Notice
1. Geller~ll Rille
An individual has a right to adequate notice of the uses and
disclosures of PHI that may be made by the covered entity, and of
the individual's rights and the covered entity's legal duties with
respect to protected health information.
2. Exceptions
a. Group Health Plans
i. An individual enrolled in a group health plan has a
right to notice:
(A) From the group health plan, if, and to the
extent that, such an individual does not
receive health benefits under the group
health plan through an insurance contract
with a health insurance issuer or HMO; or
(B) From the health insurance issuer or HMO
with respect to the group health plan through
which such individuals receive their health
benefits under the group health plan.
ii. A group health plan that provides health benefits
solely through an insurance contract with a health
insurance issuer or HMO, and that creates or
receives PHI in addition to summary health
information as defined in 45 C.F.R. § 164.504(a) or
information on whether the individual is
participating in the group health plan, or is enrolled
in or has disenrolled from a health insurance issuer
or HMO offered by the plan, must:
(A) Maintain a notice under this section; and
(B) Provide such notice upon request to any
person. The provisions of 45 C.F.R. §
B -16
164.520(c)( 1) do not apply to such group
health plan.
111. A group health plan that provides health benefits
solely through an insurance contract with a health
insurance issuer or HMO, and does not create or
receive PHI other than summary health information
as defined in 45 C.F.R. § 164.504(a) or information
on whether an individual is participating in the
group health plan, or is enrolled in or has
disenrolled from a health insurance issuer or HMO
offered by the plan, is not required to maintain or
provide a notice under this section.
b. Inmates
An inmate does not have a right to a notice of privacy
practices, and the requirements of 45 C.F.R. § 164.520 do
not apply to a correctional institution that is a covered
entity.
c. I~equired (:(.lnte.llts of .Notice
'I-'he n()tice rnust be \vritten in l)lain language and ITlllst contain the
foll(}\ving elenlents:
1. the following statement as a header or otherwise prominently
displayed: "THIS NOTICE DESCRIBES HOW MEDICAL
INFORMATION ABOUT YOU MAY BE USED AND
DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS
INFORMATION. PLEASE REVIEW IT CAREFULLY."
2. A description, including at least one example, of the types of uses
and disclosures that the covered entity is permitted by Subpart E of
the Privacy Rule to make for each of the following purposes:
treatment, payment, and health care operations. If a use or
disclosure for any purpose described is prohibited or materially
limited by other applicable law, the description of such use or
disclosure must reflect the "more stringent" law as that term is
defined in 45 C.F.R. §160.202. For each purpose described, the
description must include sufficient detail to place the individual on
notice of the uses and disclosures that are permitted or required by
Subpart E of the Privacy Rule and· other applicable law.
3. A description of each of the other purposes for which the covered
entity is permitted or required by Subpart E of the Privacy Rule to
use or disclose PHI without the individual's written consent or
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authorization. If a use or disclosure for any purpose described is
prohibited or materially limited by other applicable law, the
description of such use or disclosure must reflect the "more
stringent" law as that term is defined in 45 C.F.R. §160.202. For
each purpose described, the description must include sufficient
detail to place the individual on notice of the uses and disclosures
that are permitted or required by Subpart E of the Privacy Rule and
other applicable law.
4. A statement that other uses and disclosures will be made only with
the individual's written authorization and that the individual may
revoke such authorization as provided by 45 C.F.R. § 164.508(b)
(5).
5. If the covered entity intends to engage in any of the following
activities, the description required by paragraph 2 above must
include a separate statement, as applicable, that:
a. The covered entity may contact the individu~I to provide
appointment reminders or information about treatment
alternatives or other health-related benefits and services
that may be of interest to the individual;
b. The covered entity may contact the individual to raise funds
for the covered entity; or
c. A group health plan, or a health insurance issuer or HMO
with respect to a group health plan, may disclose protected
health information to the sponsor of the plan.
6. A statement of the individual's rights with respect to protected
health information and a brief description of how the individual
may exercise these rights, as follows:
a. The right to request restrictions on certain uses and
disclosures of PHI as provided by 45 C.F.R. § 164.522(a),
including a statement that the covered entity is not required
to agree to a requested restriction;
b. The right to receive confidential communications of PHI as
provided by 45 C.F.R. § 164.522(b), as applicable;
c. The right to inspect and copy PHI as provided by 45 C.F.R.
§ 164.524;
d. The right to amend PHI as provided by 45 C.F.R. §
164.526;
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e. The right to receive an accounting of disclosures of PHI as
provided by 45 C.F.R. § 164.528; and
f. The right of an individual, including an individual who has
agreed to receive the notice electronically in accordance
with paragraph 45 C.F.R. § 164.520(c)(3), to obtain a paper
copy of the notice from the covered entity upon request.
7. A statement that the covered entity is required by law to maintain
the privacy of PHI and to provide individuals with notice of its
legal duties and privacy practices with respect to PHI;
8. A statement that the covered entity is required to abide by the
terms of the notice currently in effect;
9. For the covered entity to change a practice described in the notice
to PHI that the covered entity created or received prior to issuing a
revised notice, in accordance with 45 C.F.R. § 164.530(i)(2)(ii), a
statement that it reserves the right to change the terms of its notice
and to make the new notice provisions effective for all PHI it
maintains. The covered entity must also describe how it will
provide individuals with a revised notice;
10. A statement that individuals may complain to the covered entity
and to the Secretary of HHS if they believe their privacy rights
have been violated, a brief description of how the individual may
file a complaint with the covered entity, and a statement that the
individual will not be retaliated against for filing a complaint.
11. The name, or title, and telephone number of a person or office to
contact for further information as required by 45 C.F.R. § 164.530
(a)(I)(ii).
12. The date on which the notice is first in effect, which may not be
earlier than the date on which the notice is printed or otherwise
published.
D. Opti(Jnall~lelncnts ()f N{)t.ice
If a covered entity elects to limit the uses or disclosures that it is permitted
to make under Subpart E of the Privacy Rule, the covered entity may
describe its more limited uses or disclosures in its notice, provided that the
covered entity may not include in its notice a limitation affecting its right
to make a use or disclosure that is required by law or permitted by 45
C.F.R. § 164.512(j)(l)(i). For the covered entity to apply a change in its
more limited uses and disclosures to PHI created or received prior to
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issuing a revised notice, in accordance with 45 C.F.R. § 164.530(i)(2)(ii),
the notice must include the statements required by paragraph 9 above.
Revisi()ns tC) Nf)tice
The covered entity must promptly revise and distribute its notice whenever
there is a material change to the uses or disclosures, the individual's rights,
the covered entity's legal duties, or other privacy practices stated in the
notice. Except when required by law, a material change to any term of the
notice may not be implemented prior to the effective date of the notice in
which such material change is reflected.
1. Gelleral Re(lllirenlellt
l\ c()vere.d entity 111Ust Inake the notice require.d 11Y the l)rivacy
Rule. available on reclucst t.o any person.
2. Specific Re<luirements f()r I-Iealtll Plalls
a. A health plan must provide notice:
i. No later than the compliance date for the health
plan, to individuals then covered by the plan;
11. Thereafter, at the time of enrollment, to individuals
who are new enrollees; and
i. Within 60 days of a material revision to the notice,
to individuals then covered by the plan.
b. No less frequently than once every three years, the health
plan must notify individuals then covered by the plan of the
availability of the notice and how to obtain the notice.
c. The health plan satisfies the requirements of this section if
notice is provided to the named insured of a policy under
which coverage is provided to the named insured and one
or more dependents.
d. If a health plan has more than one notice, it satisfies the
requirements of this section by providing the notice that is
relevant to the individual or other person requesting the
notice.
3. Specific .llc(IllirCltlell.ts for Certain Provjc}ers
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A covered health care provider that has a direct treatment
relationship with an individual must:
a. Provide the notice no later than the date of the first service
delivery, including service delivered electronically, to such
individual after the compliance date for the provider;
b. If the provider maintains a physical service delivery site:
1. Have the notice available at the service delivery site
for individuals to request to take with them; and
ii. Post the notice in a clear and prominent location
where it is reasonable to expect individuals seeking
service from the covered health care provider to be
able to read the notice; and
c. Whenever the notice is revised, make the notice available
upon request on or after the effective date of the revision
and promptly comply with the requirements of paragraph
(b) immediately above, if applicable.
4. Specific ReqllirClnents f()r Electr())lic N()tices
a. A covered entity that maintains a web site that provides
information about the covered entity's customer services or
benefits must prominently post its notice on the web site
and make the notice available electronically through the
web site.
b. A covered entity may provide the noti'ce required by this
section to an individual bye-mail, if the individual agrees
to electronic notice and such agreement has not been
withdrawn. If the covered entity knows that the e-mail
transmission has failed, a paper copy of the notice must be
provided to the individual. Provision of electronic notice by
the covered entity will satisfy the provision requirements of
45 C.F.R. § 164.520(c) when timely made in accordance
with the rules governing specific requirements for notices
given by health plans or the rules governing specific
requirements for notices given by providers listed above.
c. For purposes of paragraph (3)(a) above, if the first service
delivery to an individual is delivered electronically, the
covered health care provider must provide electronic notice
automatically and contemporaneously in response to the
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individual's first request for service.
d. The individual who is the recipient of electronic notice
retains the right to obtain a paper copy of the notice from a
covered entity upon request.
G. .To.iut Not.ices by Separate Covered J.:ntities
Covered entities that participate in organized health care arrangements
may comply with 45 C.F.R. § 164.520 by a joint notice, provided that:
1. The covered entities participating in the organized health care
arrangement agree to abide by the terms of the notice with respect
to PHI created or received by the covered entity as part of its
participation in the organized health care arrangement;
2. The joint notice meets the implementation specifications in III.C.,
except that the statements required by that section may be altered
to reflect the fact that the notice covers more than one covered
entity; and
a. Describes with reasonable specificity the covered entities,
or class of entities, to which the joint notice applies;
b. Describes with reasonable specificity the service delivery
sites, or classes of service delivery sites, to which the joint
notice applies; and
c. If applicable, states that the covered entities participating in .
the organized health care arrangement will share PHI with
each other, as necessary to carry out TPO relating to the
organized health care arrangement.
3. The covered entities included in the joint notice must provide the
notice to individuals in accordance with the applicable
implementation specifications of III.F. Provision of the joint notice
to an individual by anyone of the covered entities included in the
joint notice will satisfy the provision requirement of III.F. with
respect to all others covered by the joint notice.
Note: Covered entities that participate in an organized health care
arrangement and have a joint notice may use a joint consent form. A joint
consent must:
• Include the name or other specific identification of the
covered entities, or classes of covered entities, to which the joint
consent applies; and
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• Meet the requirements of 45 C.F.R. § 164.506, except that
the statements required by that section may be altered to reflect the
fact that the consent covers more than one covered entity.
If an individual revokes a joint consent, the covered entity that receives the
revocation must inform the other entities covered by the joint consent of
the revocation as soon as is practicable. See 45 C.F.R. § 164.506(f).
H. D(}cumentut.i()n and Retentioll of Not.ices
A covered entity must document compliance with the notice requirements
by retaining copies of the notices issued by the covered entity as required
by § 164.5300), i.e., six years from the date of the creation of the notice or
the date it was last in effect, whichever is later.
B-23

SELECTION OF THE PRIVACY OFFICER
AND AN ANALYSIS OF THE PRIVACY OFFICER'S DUTIES
Jacqueline C. Kingsolver
Associate General Counsel
Norton Healthcare
Louisville, Kentucky
Copyright 2002. Jacqueline C. Kingsolver. All rights reserved.
SECTIONC

SELECTION OF THE PRIVACY OFFICER
AND AN ANALYSIS OF THE PRIVACY OFFICER'S DUTIES
I. Requirements Of HIPAA Regulations C-I
TI. Selection Of The Privacy Officer C-I
A. Who is the Privacy Officer? C-2
B. What Are the Criteria for the Job? C-3
C. What are Reasonable Expectations of the Privacy Officer? C-4
III. Responsibilities Of The Privacy Officer C-4
A. Regulations C-4
1. Development of Privacy Policies C-5
2. Other Initial Tasks C-5
3. Follow-Up Responsibilities C-6
B. Additional Responsibilities C-7
1. Other HIPAA Obligations C-7
C. Looking Ahead C-9
Additional Resources C-II
SECTIONC

SELECTION OF THE PRIVACY OFFICER
AND AN ANALYSIS OF THE PRIVACY OFFICER'S DUTIES
March 15, 2002
Jacqueline C. Kingsolver
Associate General Counsel
Norton Healthcare
Louisville, Kentucky
I. Requirements of HIPAA Regulations
A. Section 164.530(a)(1) of the HIPAA r~gulations provides as follows:
Standard: personnel designations. (i) a covered entity must designate a
privacy official who is responsible for the development and implementation
of the policies and procedures of the entity.
B. Section (2) of the same reg.ulation provides:
Implementation specification: personnel designations. A covered entity
must document the personnel designations in paragraph (a)(l) of this section
as required by paragraph (j) of this section.
C. Paragraph (j)(1) of this same regulation provides:
Standard: documentation. A covered entity must:
(i)
(ii)
(iii) If an action, activity, or designation is required by this subpart to be
documented, maintain a written or electronic record of such action,
activity or designation..
D. Paragraph (j)(2) of the same regulation provides:
Implementation specification: retention period. A covered entity must
retain the documentation required by paragraph (j)(1) of this section for six
years from the date of its creation or the date when it last was in effect,
whichever is later.
II. Selection of the Privacy Officer
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A. Who Is the Privacy Officer? In much the same fashion as the compliance
officer of an entity, the privacy officer holds a position which serves the entire
entity and is a front line of defense to assure the entity is meeting its obligations
under the law. The federal regulations do not inclLJde a job description for the
privacy officer.
1. The comments to the federal regulations [65 FR 82462, *82744,
(December 28, 2000)] acknowledge that the privacy officer role may
be an additional responsibility given to an existing employee, such as
an office manager in a small entity (a physician's office), or an
information officer, or even the compliance officer. In smaller
organizations, this will be the most likely arrangement. It should be
noted, however, that the HIPAA-required information security officer
role is not compatible with that of the privacy officer, and may not be
a natural fit when combining roles. The security officer is responsible
for assuring the technical security of confidential information and, as a
rule, will be drawn from persons with expertise in information
systems. This person may not have the familiarity with actual patient
records or processes for amending them or handling patient
complaints regarding their confidential information. The privacy
officer should have an understanding of the organization's operations
(like medical records processes).
2. The comments do point out, however, that the privacy officer role
must serve as the single focal point for accountability. While the
duties may be delegated and shared, the single focal point must be
established. Multi-facility organizations may elect to have a single
privacy officer, but identify a contact person at each facility, such as
the chief nursing officer or the health information director, to handle
patient requests to obtain copies of their records, or to amend their
records, as well as to coordinate complaints associated with the use of
confidential patient information. Staff on site at the facilities will be
better able to address such matters in a timely manner than an off-site
privacy officer.
3. Likewise, the comments to the regulations acknowledge that the
privacy officer at one covered entity may also serve as the privacy
officer at another covered entity, s~ long as each entity otherwise
meets the requirements of the regulations.
4. The comments to the regulations acknowledge that entities with
multiple subsidiaries which meet the definition of "covered entity" do
not need to have a separate privacy officer for each such subsidiary if
they are designated by the entity as part of a single covered entity.
The rules permit such a designation to be made [see Section 164.504
(b) for the rules relating to this designation]. If only one covered
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entity is designated for the subsidiaries, only one privacy officer is
needed.
5. The privacy officer must be a member of or have ready, unfettered
access to senior management as the leader of the organization's
privacy program, in the same manner as does the compliance officer.
This access is necessary to assure the privacy officer's authority in the
organization is sufficient to enable himlher to coordinate the various
departments' responses to privacy issues and to oversee the ongoing
enforcement of privacy policies and education of staff. This authority
is especially essential in the relationship between the privacy officer
and medical staff members and enhances the privacy officer's ability
to inform and educate the governing board about privacy
responsibilities and the financial obligations associated with meeting
HIPAA requirements. This may involve a direct reporting
relationship to the chief executive officer, the chief financial officer, a
committee of the organization's governing board, or the managing
partner in a practice group. A reporting relationship to the compliance
officer could also be established for the privacy officer.
B. What Are the Criteria for the Job?
1. Facilities which are hiring to fill the newly-established position of
privacy officer must determine the educational and experience
requirements for the position. Even facilities which will not create a
new position of privacy officer must evaluate the qualifications of
those to whom the additional tasks of privacy officer are to be assigned
and select someone who has requisite skills.
2. Educational background can include persons with public health
degrees, medical ethics, law, or health administration, nursing or other
terminal degrees. Research and academic facilities may prefer
candidates who have degrees in particular fields of science, in addition
to the other noted degrees.
3. Relevant experience should include health care administrative
experience, excellent oral and written communications and
organizational skills. An important attribute in the role of privacy
officer will be the ability to work collaboratively with others as well as
the ability to problem-solve. The ability to understand, interpret,
implement and communicate federal regulations is also critical. If the
responsibility for education of the facility workforce on HIPAA is not
delegated, then the privacy officer should be experienced in training or
public speaking and in the development of training materials. The
privacy officer should also be able to manage the budget allocated for
privacy compliance efforts.
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4. Privacy officers should be capable of assuming their role quickly, as
there is a steep learning curve associated with the position. In the
context of both education of staff and interface with management and
the board, the privacy officer should be capable of handling issues as
they develop and exercising authority.
5. Salary ranges for privacy officers will vary widely, according to the
size of the organization and the position of the privacy officer within
the organization. A reasonable comparison would be to the salary of
the entity's compliance officer.
c. What are Reasonable Expectations of the Privacy Officer?
1. To enable the privacy officer to accoDlplish the assigned tasks, the
entity must assure that the officer has the suppOl1 of the governing
board and management. This support involves not only financial
support to meet HIPAA requirements, but also the means to access
top level decision makers. Board members and senior management
must be informed about the requirements of HIPAA and the role the
privacy officer is obligated to play in meeting those requirements.
Minutes of governing board meetings should reflect that the privacy
program of the entity has been explained to the board and its overall
direction approved and should reflect board approval of the job
description for the privacy officer and may also include actual
approval of the person selected for that position, to comply witll tIle
docunlentation requirements of Section j( 1) noted above. Individual
policies to support its inlplementation do not require board approval,
however.
2. The governing board should also clarify that the privacy officer,
when acting in that capacity on behalf of the entity, is covered by the
entity's directors and officers liability insurance coverage. The
HIPAA regulations do not assign personal liability to the privacy
officer for violations, although the entity can be subject to fines.
Under the criminal liability provisions of the law, the risk of personal
liability is greater since an organization cannot be held crinlinally
liable. Such occurrences would be rare, however, as in when a
person takes confidential patient information and sells it for profit.
So long as the privacy officer acts under the auspices and direction of
the governing board, there should not be personal liability
attributable to the officer.
III. Responsibilities of the Privacy Officer
A. Regulations. The regulations, and the acconlpanying conmlentary, charge
the privacy officer with serving as the central point of accountability within each
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covered entity for privacy-related issues.
1. Development of Privacy Policies,.
a. Creation of privacy policies requires 'In initial assessment of the
entity's existing policies-what does it"already have in place which
relates to confidentiality and privacy of patient information and
which can be modified to meet HIPAA requirements? What gaps
need to be filled with new policies and procedures? The privacy
officer should lead this initial assessment.
b. The privacy officer should bring together internal resources of the
entity, those with a stake in the handling of patient information, as a
task force or committee. Those stakeholders include representatives
of health information systems, human resources, information
systems., legal, op.erations, nursing, finance, risk management,
marketing, fund-raising, security, and public relations.
c. The privacy office, as head of this task force, should have the
authority to facilitate integration between the various stakeholders in
the organization as they jointly develop the necessary policies and
procedures.
d. The privacy officer must also be familiar with any applicable state
laws which impact privacy and how they must be correlated with
HIPAA's requirements in the entity's policies and procedures.
·2. Other Initial Tasks
a. Either through the assistance of task force nlembers or, in smaller
entities, on hislher own, the privacy officer is responsible for such
initial tasks as developing an inventory of the locations in the entity
where patient information is received, generated, stored and
transmitted. Such locations can include billing databases, personal
computers and handheld computers, and medical records
transcription sites.
b. Another start-up responsibility is the development of the facility's
own Privacy Notice, as required under the HIPAA regulations.
This notice should identify the privacy officer and other privacy
contacts at the entity, so patients can obtain additional infornlation
or make requests permitted under HIPAA regarding the handling
and release of their confidential information. The regulations
outline the basic required elements of the notice, but many optional
areas exist which the privacy officer must review and determine
how the facility will respond. For example, HIPAA offers facilities
the opportunity to release information to law enforcement officials
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which may be more liberal in approach than the existing approach
of many facilities. The privacy officer must lead the entity through
an analysis of its current practices and determine whether it wants
to broaden or narrow its policies on release of information to law
enforcement agencies. This can inv.olve an evaluation of the
entity's ongoing need for a good relationship with law enforcement
agencies and the public as balanced with the obligations to respect
and protect the privacy of patient information. This policy must be
. addressed in the Privacy Notice.
c. Under the privacy officer's direction, the entity must prepare to
educate its workforce in HIPAA requirements for confidentiality of
patient information. This includes orientation for new employees
and training of existing personnel. Of equal importance will be
education of physicians and other health care practitioners who
routinely require access to confidential patient information
maintained by the entity and of the governing body of the entity,
which is ultinlately responsible for assuring compliance with
.HIPAA requirements. Facilities with medical directors should
include this position in any HIPAA task force or conlmittee to
coordinate educational efforts to the medical staff.
d. Identification of current business associates of the entity is an
additional initial responsibility of the privacy officer. Inventories
are necessary of existing agreements to determine what contracts
are in place, who has copies of them, which arrangements have not
been memorialized in writing, which arrangenlents meet the
regulatory definitions of business associate arrangements, and
which will require amendments or new contracts to accommodate
the business associate regulations. The privacy officer may
develop standard language to be incorporated into amendments to
existing agreements and in new agreements as they are developed.
e. The privacy officer will also be accountable for performing a gap
analysis which identifies those areas in which compliance with
HIPAA has not yet been met and the assignment of personnel and
resources necessary to bridge those gaps in compliance. Parts of
this gap analysis will involve assessing existing policies,
procedures and practices on the creation, use, storage and release of
patient health information.
3. Follow-up Responsibilities
a. Once the initial inventory responsibilities have been completed,
the privacy officer must oversee the inlplenlentation of policies.
b. As new arrangements are entered into by the entity with third
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parties which will require access to protected patient information,
the privacy officer will be responsible for reviewing these
arrangements for compliance with HIPAA requirements.
c. The privacy officer will have ongoing responsibility for
monitoring and auditing entity activities and polices for
compliance with HIPAA and the entity's own privacy policies.
d.. The privacy officer will be responsible for monitoring existing
arrangements with business associates and identifying new
organizations which are business associates to assure contracts
include the appropriate HIPAA provisions to protect confidential
patient information shared with these business associates.
e. Any changes in the privacy policies of the entity will necessitate
revision of the Privacy Notice, which, as a rule, will be the
responsibility of the privacy officer.
f. The privacy officer must coordinate efforts with the information
security officer to avoid duplication of efforts. Whenever
possible, joint development of policies and implementation of
training should be the goal. For example, as noted below,
establishing the minimum necessary information to which each
enlployee should have access is a responsibility of the privacy
officer, but the implementation of security restrictions (access
codes, etc.) is the responsibility of the information security officer.
These two functions should be coordinated to avoid the creation of
policies to protect privacy which cannot be fulfilled due to
information system limitations.
g. Many of these follow-up responsibilities can be overseen by the
privacy officer in conjunction with a privacy oversight committee,
made up of representatives from the same areas of responsibility as
may have served on an initial HIPAA task force or conlmittee.
These include human resources, health information managenlent,
information systems and legal. The privacy officer would direct
and lead this committee.
B. Additional Responsibilities
I. Other HIPAA Obligations
a. HIPAA requires covered entities to establish complaint processes,
to establish processes under which patients can ask to anlend their
medical records and to seek an accounting of disclosures of their
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protected health information. In small facilities or physician
offices, it is likely that these responsibilities will fall to the privacy
officer. HIPAA regulations do not require that these be the
obligation of the privacy officer, however, and there may be reasons
to resist the temptation to impose them upon the privacy officer,
particularly in larger organizations. For example, the volume of
requests for access to records to review and amend them for an
. accounting of disclosures could be large and consume the privacy
officer's time. Coordination with medical records personnel in
responding to these requests will be necessary in most facilities and
medical records personnel are usually accustomed to responding to
requests for records and better equipped to handle such requests.
The privacy officer could review all such requests and forward
them for action to medical records, followed with a review of the
records by the privacy officer before they are released.
b. Section 164.502(b) of the regulations require covered entities to
make all reasonable efforts not to use or disclose more than the
minimum amount of protected health information necessary to
accomplish the intended purpose, use or disclosure. While the
regulations include six significant exceptions to this requirement,
there remains the obligation to determine "minimum necessary". It
should not be the privacy officer who makes the individual
decisions, although the officer should oversee the development of a
policy for the entity. The privacy officer may delegate the everyday
responsibility for these decisions to "experts" within the
organization with clinical expertise to determine the minimum
necessary information for various jobs. This could include nurse
directors and medical records personnel. A key spot in the
processes of most entities at which this decision can be Dlade and
communicated to employees is at the level of new hires. The hiring
manager or supervisor can identify the information to which the
new hire will have access and communicate this to the new
employee. Computer access restrictions can be used in this context
to limit access. This process serves as an interface between the
privacy function and the information security function. The privacy
officer can oversee this process and serve as a problem-solver,
while day-to-day decisions and implementation can be assigned to
front-line managers and supervisors.
c. The regulations require covered entities to develop their own
internal system of sanctions for violations by employees and
business associates. These can and should include termination of
employees and the termination of agreements with business
associates. The privacy officer, in conjunction with the human
resources department, should monitor employee violations and
related discipline. The ability to report on such disciplinary actions
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arising from HIPAA violations is important to the privacy officer's
ability to affirm the entity's efforts at enforcement. The privacy
officer should be the responsible party for enforcement against
business associates and coordinate regular audits of their activities,
with reports also available of these audit activities and actions taken
in response to violations.
c. Looking Ahead
1. The privacy officer will be responsible for addressing future
problems in compliance with HIPAA. Potential problems an
entity may face include delays in meeting the privacy compliance
deadline, including getting new policies in place and completing
necessary education; breaches of confidentiality by employees,
business associates and others; failing to promptly and correctly
respond to patient request permitted under HIPAA (including
requests for accountings of releases of information and requests to
amend patient medical records). The privacy officer, with the
assistance of a privacy committee, should have in place
contingency plans to assist in reacting to such problems. This
would include the processes for enlisting additional resources,
handling media inquiries, reporting breaches, as required, to
appropriate authorities, coordinating disciplinary actions and
terminations of agreements with business associates.
2. Coordination with marketing and public relations personnel will
be important for those entities which choose to promote to the
public the entity's advances in technology, security and privacy.
3. The privacy officer will be responsible for meeting requirements
of JCAHO as it expands its accreditation standards to incorporate
the requirements of HIPAA. Surveys after April 2003 likely will
consider the entity's compliance with privacy standards.
Preparation for surveys will require inclusion of HIPAA
compliance and review of implementing policies. Audits by the
Office of Civil Rights of eMS, which is charged with
enforcement of HIPAA, will include surveys of HIPAA
compliance as well.
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ADDITIONAL RESOURCES
For more information about HIPAA in general and about the rules relating to privacy
officers, the following web sites are available resources:
,,'\\'\\'.hcfa.gov/facts/f2702as.htm
\\'\V\V.hhs.gov/ocrlhipaa
http://aspe.os.dhhs.gov/admnsimp/
\\'\\'\v.himinfo.com
www.ahima.orglhipaaIPrivacyOfficer200J.htm
\\'\\,\\'.aba.orBlhipaa
\\'\V\\' .healthlawyers.org
\\'WW.healthprivacy.org
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1. The Minimum Necessary Standard • § 164-.502(b)
A. When using or disclosing Protected Health Information, or when requesting
Protected Health Information from another Covered Entity, a Covered Entity must
make reasonable efforts to limit Protected Health Information to the minimum
necessary to accomplish the intended purpose of the use, disclosure of request.
Comment: The Final Rule deleted the requirement
that the Covered Entity make "all" reasonable efforts
to limit necessary disclosures.
Comment: This is a flexible standard which takes into
account the ability of the Covered Entity to configure
its record system to allow selective access, such as
limitations to only certain fields in a computerized
information system, which may not be reasonable for
a Covered Entity with a largely paper records system~
B. This requirement does not apply to:
(i) Disclosures made to or by a health care provider for treatment.
Comment: This exception to the disclosure rules also
applies to mental health information. Providers may
use existing ethical duties to limit the sharing of
unnecessary medical information.
Comment: Note that the minimum necessary
disclosure rules do apply to uses and disclosures for
payment or health care operations.
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(ii) Uses or disclosures made to the Individual, or pursuant to an
Authorization, except for Authorizations requested by the Covered Entity
under §§164.508(d), (e) or (f).
(iii) Disclosures made to the Secretary of HHS pursuant to a complaint
brought under HIPAA in accordance with 45 CFR § 160, Subpart C.
(iv) Uses or disclosures required by law as described in §164.512(a).
Comment: Nothing in this rule permits Covered Entity
to avoid disclosures required 'by other laws.'
Comment: But, the rule does apply to ,disclosures to
authorities which not required by law; but §164.514(h)
allows Covered Entities to reasonably rely on the oral
or written representation of public officials that a
disclosure is required by law.
(v) Uses or disclosures required for compliance with applicable
requirements of 45 CFR Subtitle A, Subchapter C, Le., the required or
situational data elements specified in the implementation guides for
HIPAA administrative simplification standard transactions in the
Transactions Rule.
Comment: The standard does apply to uses or
disclosures in standard transactions that are made at
the option of the Covered Entity.
2. Implementing the Minimum Necessary Standard • §164.514(d)
A. A Covered Entity must reasonably ensure that the standards, requirements,
and implementation specifications of §§164.502(b) and 164.514 relating to a
request for or the use or disclosure of the minimum necessary Protected Health
Information are met.
B. Minimum Necessary Uses of Protected Health Information
(i) A Covered Entity must identify:
(1) Those persons or classes of persons, as appropriate, in the
workforce who need access to Protected Health Information to
carry out their duties; and
(2) For each such person or class of persons, the category or
categories of Protected Health Information to which access is
needed and any conditions appropriate to such access.
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(ii) A Covered Entity must make reasonable effort to limit the access of
such persons or classes identified herein consistent with such
classifications.
'Comment: This requirement to implement policies
and procedures is in lieu of making a minimum
necessary determination on a case by case ~asis.
Comment: This is a substantial change from the
proposed rule which required procedures to: (i)
identify appropriate persons within the entity to
determine what information should be disclosed
consistent with the minimum necessary standard; (ii)
ensure that those persons make the necessary
determinations; and (iii) within the limits of the entity's
technological capabilities, provide for the making of
such determinations individually.
Comment: The proposed rule described' certain
criteria (which were not included in the regulatory text)
which were used to determine what was a reasonable
effort under this section: (i) the amount of information
disclosed; (ii) the number of individuals who would
then have access to the Protected Health Informa-tion;
(iii) the likelihood that further uses or disclosures
could occur; (iv) the importance of the use or
disclosure; (v) the potential to achieve the same
purpose with de-identified information; (vi) the
technology available to limit the amount of Protected
Health Information used or disclosed; (vii) the cost of
limiting the use or disclosure; and (viii) any other
factors that the entity believed were relevant to the
determination.
Example: A hospital could permit nurses access to all
Protected Health Information of patients in their ward
while on duty, but should not permit appointment
scheduling clerks free access to medical records.
Example: A health plan could permit its underwriting
analyst unrestricted access to aggregate claims data,
but require documented approval of a department
manager to obtain identifiable records' of a specific
member for the pU,rpose of determining a cause of
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unexpected claims that could influence renewal
premium rate setting.
Comment: Covered Entities are expected to allow
persons involved in treatment to have access to the
entire medical record.
c. Minimum Necessary Disclosures of Protected Health Information
(i) For any type of disclosure that it makes on a routine and recurring
basis. a Covered Entity must implement policies and procedures (which
may be standard protocols) that limit the Protected Health Information
disclosed to the amount reasonably necessary to achieve the purpose of
the disclosure.
Comment: Individual review is not required. but
policies must identify the types of Protected Health
Information to be disclosed. the types of person to
receive the Protected Health Information, and the
conditions for access.
Example: A Covered Entity may require a researcher
requesting data contained in paper-based records to
review the records on-site and to abstract only the
information relevant to the research.
Example: With regard to Business Associates, a
standard protocol could describe the subset of
information that may be disclosed to medical
transcription services.
(ii) For all other [i.e., non-routine] disclosures. a Covered Entity must:
(1) Develop [reasonable] criteria designed to limit the Protected
Health Information disclosed to the information reasonably
necessary to accomplish the purpose for which the disclosure is
sought; and
(2) Review requests for disclosure on an individual basis in
accordance with such criteria.
Comment: Disclosures to health care providers for
treatment purposes are not subject to these
requirements.
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(iii) A Covered Entity may rely, if such reliance is reasonable under the
circumstances, on a requested disclosure as the minimum necessary for
the stated purpose when:
(1) Making disclosures to public officials that are permitted under
§164.512, if the public official represents that the information
requested is the minimum necessary for the stated purpose(s);
Comment: The Final Rule specifically allows Covered
Entities to use or disclose Protected Health
Information without individual agreement to federal,
state or local government agencies, or private
disaster assistance or relief organizations (such as
the Red Cross), so as not to impede their mission to
save lives and reunite loved ones and families in
disaster situations. §164.51o(b)(4)
(2) The information is requested by another Covered Entity;
Comment: The disclosure rules apply to requests by
Covered Entities, but one Covered Entity may rely on
the assertion of a requesting Covered Entity that it is
requesting only the minimum necessary Protected
Health Information. Recall, however, that the
disclosure rules do not apply to provider requests for
treatment purposes.
(3) The information is requested by a professional who is a
member of the workforce or is a Business Associate of the Covered
Entity for the purpose of providing professional services to the
Covered Entity, if the professional represents that the information
requested is the minimum necessary for the stated purpose(s); or
Comment: The minimum necessary disclosure rules
apply to Business Associates, although you can use
standard protocols for routine disclosures and rely
upon representations of professionals.
(4) Documentation or representations that comply with §164.512(i)
have been provided by a person requesting the information for
research purposes.
Comment: The documentation should come from an
Institutional Review Board or privacy board, and
should describe with sufficient specificity the
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Protected Health Information'necessary for the
research.
D. Minimum Necessary Requests for Protected Health Information
i) A Covered Entity must limit any request for Protected Health
Information to that which is reasonably necessary to accomplish the
purpose for which the request is made, when requesting such information
from another Covered Entity.
(ii) For areq'uestfhatis made'on'a r6'utir'leor'recuriing basis, a Covered
Entity must implement policies and procedures (which may be standard
protocols) that limit the PHI requested to the amount reasonably
necessary to accomplish the purpose for which the request is made.
Comment: Creation and implementation of these
policies is in lieu of making individualized
determinations for each request.
(iii) For all other [Le., non-routine] requests, a Covered Entity must review
the request on an individual basis to determine that the Protected Health
Information sought is limited to the information reasonably necessary to
accomplish the purpose for which the request is made.
E. Other Content Requirements • §164.514(d)(5) - For all uses, disclosures or
requests to which the minimum necessary requirements apply, a Covered Entity
may not use, disclose or request an entire medical record, except when the
entire medical record is specifically justified as the amount that is reasonably
necessary to accomplish the purpose of the use, disclosure or request.
Example: Disclosure of all Protected Health
Information to an accreditation group may be the
"minimum necessary" for its purposes, thus justifying
a policy for ~uch disclosure.
Example: A health plan's request for all Protected
Health Information from an applicant for insurance
may be appropriate if the entire record is the
"minimum necessary" for its purpose, thus justifying a
policy for such request.
Comment: Disclosure of the entire medical record
absent such documented justification is a presumptive
violation of this rule.
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F~ The Minimum Necessary Standard for Financial Transactions •
§164.510(i)
(i) A Covered Entity may disclose. in connection with routine banking
activities or payment by debit. credit, or other payment card, or other
payment means, the minimum amount of Protected Health Information
necessary to complete a banking or payment activity to:
(1) A financial Institution (as defined by section 101 of the Right to
Financial Privacy Act of 1978); or
(2) An entity engaged in authorizing, processing. clearing, settling,
billing. transferring, reconciling. or c911ecting payments, for such a
financial institution.
Comment: The information that will generally be
needed: the name and address of the individual; the
name and address of the payer or provider; the
amount of the charge for the health service; the date
on which the health service was rendered; the
expiration date of the payment mechanism; the
individual's signature; and relevant identification and
account numbers.
Comment: We clarify that "pharmacy benefit cards."
as well as other health benefit cards, are used for
identification of individual, plan. and benefits and do
not qualify as "other payment cards."
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MINIMUM NECESSARY
[45 CFR §§ 164.502(b), 164.514(d)]
General Requirement
The Privacy Rule generally requires covered entities to take reasonable steps to limit the use
or disclosure of, and requests for protected health infonnation (PHI) to the minimum necessary
to accomplish the intended purpose. The minimum- necessary provisions do not apply to the
follo\ving:
· Disclosures to or requests by a health care provider for treatment purposes.
· Disclosures to the individual who is the subject of the infonnation.
· Uses or disclosures made pursuant to an authorization requested by the individual.
· Uses or disclosures required for compliance with the standardized Health Insurance
Portability and Accountability Act (HIPAA) transactions. ,
· Disclosures to the Department ofHealth and Human Services (HHS) when disclosure of
infonnation is required under the rule for enforcement purposes.
· Uses or disclosures that are required by other law.
The implementation specifications for this provision require a covered entity to develop and
implement policies and procedures appropriate for its own organization, reflecting the entity's
business practices and workforce. We understand this guidance will not answer all questions
pertaining to the minimum necessary standard, especially as applied to specific industry
practices. As more questions arise with regard to application of the minimum necessary standard
to particular circumstances, we will provide more detailed guidance and clarification on this
Issue.
Uses and Disclosures of, and Reguests.for PHI
For uses of PHI, the policies and procedures must identify the persons or classes ofpersons
within the covered entity who need access to the infonnation to carry out their job duties, the
categories or types ofPHI needed, and conditions appropriate to such access. For example,
hospitals may implement policies that pennit doctors, nurses, or others involved in treatment to
have access to the entire medical record, as needed. Case-by-case review ofeach use is not
required. Where the entire medical record is necessary, the covered entity's policies and
procedures must state so explicitly and include a justification.
For routine or recurring requests and disclosures, the policies and procedures may be
standard protocols and must limit PHI disclosed or requested to that which is the minimum
necessary for that particular type ofdisclosure or request. Individual revie\v ofeach disclosure
or request is not required.
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For non-routine disclosures, covered entities must develop reasonable criteria for
determining, and limiting disclosure to, only the minimum amount ofPHI necessary to
accomplish the purpose of a non-routine disclosure. Non-routine disclosures must be reviewed
on an individual basis in accordance with these criteria. When making non-routine requests for
PHI, the covered entity must review each request so as to ask for only that information
reasonably ne'cessary for the purpose of the request.
Reasonable Reli.ance
In certain circumstances, the Privacy Rule pennitsa covered entity to rely on the judgment
of the party requesting the disclosure as to the minimum amount ofinfonnation that is needed.
Such reliance must be reasonable under the particular circumstances of the request. This reliance
is permitted when the request is made by:
· A public official or agency for a disclosure pennitted under §164.S12 ofthe rule.
· Another covered entity.
· A professional who is a workforce member or business associate ofthe covered entity
holding the information.
· A researcher with appropriate documentation from an Institutional Review Board (IRB)
or Privacy Board.
The rule does not require such reliance, however, and the covered entity always retains
discretion to make its own minimum necessary detennination for disclosures to which the
standard applies.
Treatment Settines
We understand that medical information must be conveyed freely and quickly in treatment
settings, and thus understand the heightened concern that covered entities have about how the
minimum necessary standard applies in such settings. Therefore, we are taking the following
steps to clarify the application of the minimum necessary standard in treatment settings. First,
\ve clarify some of the issues here, including the application ofminimum necessary to specific
practices, so that covered entities may begin implementation of the Privacy Rule. Second, we
\vill propose corresponding changes to the regulation text, to increase the confidence of covered
entities that they are free to engage in whatever communications are required for quick, effective,
high quality health care. We understand that issues of this importance need to be addressed
directly and clearly to eliminate any ambiguities.
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Frequentlv Asked ouestions
Q: How are covered entities expected to determine what is the minimum necessary
information that can be used, disclosed, or requested for a particular purpose?
A: The Privacy Rule requires a covered entity to make reasonable efforts to limit use,
disclosure ot: and requests for PHI to the minimum necessary to accomplish the intended
purpose. To allow covered entities the flexibility to address their unique circumstances, the rule
requires covered entities to make their own assessment ofwhat PHI is reasonably necessary for a
particular purpose, given the characteristics of their business and workforce, and to implement
policies and procedures according~y. This is not a strict standard and covered entities need not
limit information uses or disclosures to those that are absolutely needed to serve the purpose.
Rather, this is a reasonableness standard that calls for an approach consistent with the best
practices and guidelines already used by many providers today to limit the unnecessary sharing
ofmedical infonnation.
The minimum necessary standard is intended to make covered entities evaluate their
practices and enhance protections as needed to prevent unnecessary or inappropriate access to
PHI. It is intended to reflect and be consistent with, not override, professional judgment and
standards. Therefore, we expect that covered entities will utilize the input ofprudent
professionals involved in health care activities when developing policies and procedures that
appropriately will limit access to personal health infonnation without sacrificing the quality of
health care.
Q: \Von't the minimum necessary restrictions impede the delivery of quality health care
by preventing or hindering necessary exchanges of patient medical information among
health care providers involved in treatment?
A: No. Disclosures for treatment purposes (including requests for disclosures) between health
care providers are explicitly exempted from the minimum necessary requirements.
The Privacy Rule provides the covered entity with substantial discretion as to how to
implement the minimum necessary standard, and appropriately and reasonably limit access to the
use of identifiable health infonnation within the covered entity. The rule recognizes that the
covered entity is in the best position to know and detennine who in its workforce needs access to
personal health infonnation to perform their jobs. Therefore, the covered entity can develop
role-based access policies that allow its health care providers and other employees, as
appropriate, access to patient information, including entire medical records, for treatment
purposes.
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Q: Do the minimum necessary requirements prohibit medical residents, medical students,
nursing students, and other medical trainees from accessing patients' medical
information in the course of their training?
A: No. The defInition of "health care operations" in the rule provides for "conducting
training programs in which students, trainees, or practitioners in areas ofhealth care learn under
supervision to practice or improve their skills as health care providers." Covered entities can
shape their policies and procedures for minimum necessary uses and disclosures to pennit
medical trainees access to patients' medical infonnation, including entire medical records.
Q: Must minimum necessary be applied to disclosures to third parties that are authorized
by an individual?
A: No, unless the authorization was requested by a covered entity for its own purposes. The
Privacy Rule exempts from the minimum necessary requirements most uses or disclosures that
are authorized by an individual. This includes authorizations covered entities may receive
directly from third parties, such as life, disability, or casualty insurers pursuant to the patient's
application for or claim under an insurance policy. For example, if a covered health care
provider receives an individual's authorization to disclose medical information to a life insurer
for underwriting purposes, the provider is pennitted to disclose the information requested on the
authorization without making any minimum necessary detennination. The authorization must
meet the requirements of §164.508.
However, minimum necessary does apply to authorizations requested by the covered entity
for its o\vn purposes (see §164.508(d), (e), and (t).
Q: Are providers required to make a minimum necessary determination to disclose to
federal or state agencies, such as the Social Security Administration (SSA) or its
affiliated state agencies, for individuals' applications for federal or state benefits?
A: No. These disclosures must be authorized by an individual and, therefore, are exempt from
the minimum necessary requirements. Further, use of the provider's o\vn authorization fonn is
not required. Providers can accept an agency's authorization fonn as long as it meets the
requirements of §164.508 of the rule. For example, disclosures to SSA (or its affiliated state
agencies) for purposes ofdetennining eligibility for disability benefits are currently made subject
to an individual's completed SSA authorization form. After the compliance date, the current
process may continue subject only to modest changes in the SSA authorization form to confonn
to the requirements in §164.508.
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Q: Doesn't the minimum necessary standard conflict \vith the Transactions standards?
Does minimum necessary apply to the standard transactions?
A: No, because the Privacy Rule exempts from the minimum necessary standard any uses or
disclosures that are required for compliance with the applicable requirements ofthe subchapter.
This includes all data elements that are required or situationally required in the standard
transactions. However, in many cases, covered entities have significant discretion as to the
infonnation included in these transactions. This standard does apply to those optional data
elements.
Q: Does the rule strictly prohibit use, disclosure, or requests of an entire medical record?
Does the rule prevent use, disclosure, or requests of entire medical records \vithout
case-by-case justification?
A: No. The Privacy Rule does not prohibit use, disclosure, or requests ofan entire medical
record. A covered entity may use, disclose, or request an entire medical record, without a case-
by-case justification, if the covered entity has documented in its policies and procedures that the
entire medical record is the amount reasonably necessary for certain identified purposes. For
uses, the policies and procedures would identify those persons or classes ofperson in the
workforce that need to see the entire medical record and the conditions, if any, that are
appropriate for such access. Policies and procedures for routine disclosures and requests and the
criteria used for non-routine disclosures would identify the circumstances under which disclosing
or requesting the entire medical record is reasonably necessary for particular purposes. In
making non-routine requests, the covered entity may also establish and utilize criteria to assist in
detennining when to request the entire medical record.
The Privacy Rule does not require that a justification be provided with respect to each
distinct medical record.
Finally, no justification is needed in those instances where the minimum necessary standard
does not apply, such as disclosures to or requests by a health care provider for treatment or
disclosures to the individual.
Q: In limiting access, are covered entities required to completely restructure existing
\vorkflo\v systems, including redesigns of office space and upgrades of computer
systems, in order to comply \vith the minimum necessary requirements?
A: No. The basic standard for minimum necessary uses requires that covered entities make
reasonable efforts to limit access to PHI to those in the workforce that need access based on their
roles in the covered entity.
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The Department generally does not consider facility redesigns as necessary to meet the
reasonableness standard for minimum necessary uses. However, covered entities may need to
make certain adjustments to their facilities to minimize access, such as isolating and locking file
cabinets or records rooms, or providing additional security, such as passwords, on computers
maintaining personal infonnation.
Covered entities should also take into account their ability to configure their record systems
to allow access to only certain fields, and the practicality oforganizing systems to allow this
capacity. For example, it may not be reasonable for a small, solo practitioner who has largely a
paper-based records system to limit access ofemployees with certain functions to only limited
fields in a patient record, while other employees have access to the complete record.
Alternatively, a hospital with an electronic patient record system may reasonably implement
such controls, and therefore, may choose to limit access in this manner to comply with the rule.
Q: Do the minimum necessary requirements prohibit covered entities from maintaining
patient medical charts at bedside, require that covered entities shred empty
prescription vials, or require that X-ray light boards be isolated?
A: No. The minimum necessary standards do not require that covered entities take any ofthese
specific measures. Covered entities must, in accordance with other provisions of the Privacy
Rule, take reasonable precautions to prevent inadvertent or unnecessary disclosures. For
example, while the Privacy Rule does not require that X-ray boards be totally isolated from all
other functions, it does require covered entities to take reasonable precautions to protect X-rays
from being accessible to the public. We understand that these and similar matters are ofspecial
concern to many covered entities, and we will propose modifications to the rule to increase
covered entities' confidence that these practices are not prohibited.
Q: 'Viii doctors' and physicians' offices be allowed to continue using sign-in sheets in
\vaiting rooms?
A: We did not intend to prohibit the use of sign-in sheets, but understand that the Privacy Rule
is ambiguous about this common practice. We, therefore, intend to propose modifications to the
rule to clarify that this and similar practices are pennissible.
Q: 'Vhat happens when a covered entity believes that a request is seeking more than the
minimum necessary PHI?
A: In such a situation, the Privacy Rule requires a covered entity to limit the disclosure to the
minimum necessary as detennined by the disclosing entity. Where the rule pennits covered
entities to rely on the ju~gment of the person requesting the infonnation, and if such reliance is
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reasonable despite the covered entity's concerns, the covered entity may make the disclosure as
requested.
Nothing in the Privacy Rule prevents a covered entity from discussing its concerns with the
person making the request, and negotiating an infotmation exchange that meets the needs ofboth
parties. Such discussions occur today and may continue after the compliance date ofthe Privacy
Rule.
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HIPAA PRIVACY COMPLIANCE PLANS
On December 28,2000, the Department for Health and Human Services (''DHHS'') published
a fmal rule regarding the privacy ofprotected health information (''PHI''). 1 The new privacy standard
authorized by the Health Insurance Portability and Accountability Act of 1996 (HIPAA), governs
a covered entity's2 use and disclosure of PHI [hereinafter the ''Privacy Rule" or ''Privacy
Regulation"]. The Privacy Rule also grants individuals certain rights with respect to their own PHI.
The privacy standard ... is destined to revolutionize the way patients, health care
providers and insurers relate to one another. In asserting that privacy is a
''fundamental right," the rule has the potential to transform the very way Americans
view their right to control all information concerning themselves.3
For a covered entity, becoming "HIPAA-compliant" entails much more than drafting a few
agreements and securing patient fues. Much like the corporate compliance plans providers and
others are already accustomed to developing in response to federal fraud and abuse laws, the HIPAA
regulations require covered entities to formulate and maintain a framework, including structured '
policies and procedures, for maintaining responsible privacy practices. A HIPAA compliance plan,
then, is a mechanism which can help guide an organization to HIPAA compliance.
The deadline for compliance with the HIPAA privacy regulations is April 14, 2003. With
about 12 months to prepare, covered entities have only a short time left to comply with HIPAA.
Although admittedly a daunting task, breaking compliance into manageable pieces is possible. This
1See 65 Fed. Reg. 82462 - 82944.
2Covered Entity means: (1) A health plan. (2) A health care clearinghouse. (3) A health care provider who
transmits any health information in electronic form in connection with a transaction covered by this subchapter. 45
CPR 160.103.
3HIPAA Patient Privacy Compliance Guide, Frances R. Fernald, 00., Atlantic Information Services, Inc.,
100:4 (2002).
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paper breaks compliance into five separate but interdependent phases. The time allotted for each
phase will vary depending on the size and function of the entity. The goal of the frrst three phases
is to prepare a "workplan." The workplan will utilize an organization's knowledge of the HIPAA
regulations as it relates to their functions (Phase One), it will provide an overview of the
organization's current privacy practices (Phase Two), and it will defme the risks of noncompliance
and prioritize the goals for the fmal two phases ofHIPAA compliance (Phase Three). Phase Four
is dedicated to actually implementing the internal changes identified as needing improvement and/or
formulation during the previous phases. The fmal phase follows implementation, and allows the
organization to adjust and troubleshoot any of the changes and also begin to comply with HIPAA's
audit and monitoring requirements.
Ie Phase 1: HIPAA Overview and Program Initiation
Most health care entities understand that they will be affected by HIPAA's privacy
regulations. Most, however, do not comprehend the extent to which the regulations will change the
way the entity operates. Because it is so important to get off to a good start with your organization's
HIPAA compliance efforts, Phase One is dedicated to understanding and communicating HIPAA
basics. Activities done in Phase One should all focus on improving the entity's knowledge of
HIPAA's requirements and designating those to lead your entity to compliance. Therefore, Phase
One of your compliance efforts should entail at least the following:
(1) Appointment of a Privacy Officer: Not only is the appointment of a
privacy officer mandated by the regulations, but this will be the person who
will lead your organization's compliance effort. 45 CPR §164.530(a)(1).
Leadership in this process is essential to getting started, to make continued
progress and to sustain the change.
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(A) The privacy officer will oversee compliance for the entire organization. This
will include access to, and uses, disclosures, and disposition of, PHI and will
entail significant interaction and collaboration with department, committee,
and clinical personnel.
(B) The privacy officer should be given enough responsibility to be capable of
implementing and overseeing your entire organization's compliance.
(C) Larger organizations may also need to establish one or more committees·to
assist the privacy officer with the development and day-to-day operations
regarding HIPAA compliance. Members of these committees could include
personnel from human resources, purchasing, claims and billing, and the
medical staff.
(2) Understand HIPAA's Requirements: The Privacy Officer and others
responsible for HIPAA compliance need to acquire knowledge and training
regarding, HIPAA's requirements. .
(3) Educate Management: Even if the management of your organization is not
participating directly in the compliance process, they also need to be educated
regarding the basic requirements and scope of HIPAA compliance.
(4) Reporting Structure: Management needs to determine how it will oversee
privacy compliance.
(5) Identify Applicable Requirements: Review the regulations to identify
policy elements and determine which ones are applicable to your
organization's select business functions. The HIPAA privacy regulations
recognize that many covered entities perform other functions which are not
covered by HIPAA or are affiliated in some way with other covered entities.
Because of this, your entity may be able to take advantage of the compliance-
related efficiencies provided in the regulations. If your organization is
considered a (1) hybrid entity, an (2) affiliated entity or is an (3) organized
health care arrangement ("OHCA") you may be able to isolate and/or
coordinate certain compliance-related functions. To determine if your
organization fits any of these organizational structures, you will need to
thoroughly assess, probably with the aid of counsel, the entire organization
and its operations from both a technical or legal perspective and also from
a practical and strategic perspective. Requirements affecting ALL covered
entities include:
(A) Appointment of a privacy official and privacy contact;
E-3
(B) Development, implementation and documentation of privacy policies and
procedures;
(C) Workforce training on privacy;
(D) Adoption of privacy safeguards for PHI;
(E) Implementation of minimum necessary guidelines for the use and disclosure
of PHI;
(F) Establishment of a complaint process for privacy violations; and
(G) Establishment of sanctions for privacy violations.
(6) Evaluation of Other Laws Includin2 a Preemption Analysis: At this stage
it is also important to assess other laws that affect how your organization is
run. Many other state and federal statutes, rules and regulations, and state
constitutions may potentially impact your organization. It is· important to
keep in mind that Congress gave HIPAA preemptive effect over certain
contrary provisions ofState law.4 Statutory parts ofHIPAA and any standard
or implementation specification adopted by the regulation shall supersede any
contrary provision of State law, including a provision of State law that
requires medical or health plan records (including billing information) to be
maintained or transmitted in written rather than electronic form. If your
organization determines it is also subject to a State law which is potentially
contrary to any of HIPAA's requirements, the organization should obtain
advice from legal counsel concerning your obligations.
(7) Budget Considerations: Although the Department of Health and Human
Services (''DHHS'') anticipates that the "net impact of the [privacy] rules will
be a net savings to the health care system," every organization can expect a
significant cost expenditure for HIPAA compliance. Your organization needs
to be aware of the potential cost involved and needs to commit funds to
complete your compliance plan. When your organization determines its
compliance budget be sure to also include the cost of any attorneys and/or
consultants your organization plans to employ for this process. In addition
to budgeting for consultants DHHS has identified the following 14 cost
components to HIPAA privacy compliance applicable to every covered
entity:5
4See 45 CPR § 160.201 et seq.
5See 65 Fed.Reg. 82765-82776.
E-4
(A) Policy development
(B) Minimum necessary
(C) Privacy official(s)
(D) Disclosure tracking/history
(E) Business associates
(F) Notice distribution
(G) Consent
(H) Inspection/Copying
(I) Amendment
""
(J) Requirements on research
(K) Training
(L) De-identification of information
(M) Employers with insured group health plans
(N) Internal complaints
(8) Attorney-Client Privileee: Phase two of your compliance plan requires an
internal risk assessment of your organization's current business practices.
Because the internal assessment may uncover potentially sensitive
information about your organization, the organization should consider
engaging legal counsel to invoke the attorney-client privilege with respect to
any fmdings.
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II. Phase 2: Compliance/Risk Assessment & Gap Analysis
Phase Two involves performing an internal assessment to determine exactly how your
organization's current level ofprivacy compares to the HIPAA requirements. A comprehensive risk
assessment includes thoroughly reviewing every operating policy, examining every contractual
arrangement, capturing where and how PHI is created, stored, transferred and shared, identifying key
personnel, and reviewing the degree of compliance among your business associates.
The frrst aspect of the internal HIPAA assessment should be to generate a checklist or
questionnaire which will help guide you through your organization's structure and allo\y you to ask
the right questions of the right people including requesting all of the needed documentation. Your
checklist can and should be created by going through your list of HIPAA requirements generated in
Phase One. Specific requirements of the Privacy Rule that every covered entity needs to address
in this phase include, but are not limited to, the following:
(1) Consents for the use and disclosure of PHI to carry out treatment, payment
or health care operations;6
(2) Uses and disclosures of PHI for which an Authorization is required;'
645 CFR § 164.506
'45 CFR § 164.508
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(3) Uses and disclosures of PHI requiring an opportunity for the individual to
agree or to 0 bject;8
(4) Uses and disclosures of PHI for which consent, authorization or opportunity
to agree or object is not required;9
(5) Notice of privacy practices;IO
(6) Patient's right to request privacy protection for their PHI;11
(7) Patient's right of access to their PHI;12
(8) Amendment of PHI;13
(9) Accounting of disclosures of PHI;14
(10) Contractual requirements for business associate relationships;15
(11) Personnel training regarding privacy policies and procedures;16 and
(12) Formal written policies and procedures concerning the entities priva.cy
policies and procedures;17
845 CPR § 164.510
945 CPR § 164.512
1045 CFR § 164.520
1145 CPR § 164.522
1245 CFR § 164.524
1345 CFR § 164.526
1445 CPR § 164.528
1545 CPR § 164.504(e)
1645 CPR § 164.530(b)
1745 CPR § 164.530U)
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After putting together a complete checklist ofHIPAA requirements, you need to determine,
according to the functions of your organization, what information you will need to know to assess
your current privacy practices. For example, the HIPAA privacy regulations require covered entities
to obtain an authorization from the individual for every use or disclosure of PHI not related to the
treatment, payment or health care operations for that individual. 45 CPR §164.508(a). An
appropriate HIPAA analysis, then, needs to include a determination of how, when and by whom an
organization uses and discloses PHI in order to determine not only the current level of compliance,
but also eventually what practices need to be changed. The sample HIPAA analysis questionnaire
in Example One demonstrates this concept.
Example 1: HIPAA Analysis Questionnaire
HIPAA Requirement
(1) Authorization. 45 1. Does the organization use PHI for purposes other than treatment, payment or health care
CPR §164.508(a) operations?
Answer:
2. If yes, how?
Answer:
3. Does the organization obtain any form of authorization prior to the use or disclosure?
Answer:
4. If yes, before every use or disclosure?
Answer:
5. Is the authorization a form or is it individualized?
Answer:
6. Attach copy of any and all authorizations used.
Answer:
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It is important to be particularly diligent in assessing the organization's relationships with
entities designated as "business associates" by the privacy rule. 18 Because the Privacy Rule does not
directly regulate business associates, it places the responsibility of monitoring business associate
conduct on the covered entity. The Privacy Rule states that a covered entity is not in compliance
with the Rule's requirements "if the covered entity knew of a pattern of activity or practice of the
business associate that constituted a material breach or violation of the business associate's
obligation under the contract or other arrangement ..."19 The business associate provisions will
undoubtedly cause your organization to reevaluate and renegotiate many of its contractual
relationships.20 Depending on the size of your organization, the process of identifying all business
associates and drafting new contracts or adding HIPAA compliant provisions could be a substantial
undertaking and therefore' should be started as soon as possible.
Some common business practices may not automatically be viewed as potential compliance
issues. The following are examples of some practices your organization should consider when
drafting and performing the risk assessment:
(1) Where are patient sign up sheets with name and other information kept?
(2) Where are patient schedules stored? Are they left in plain view?
(3) Do confidential conversations take place in areas where they can be
overheard?
(4) Are computer screens with PHI of patients left in plain view?
1845 CPR § 164.504(e).
1945 CPR §164.504(e)(ii).
20See 45 CPR §164.504(e) for Privacy Rule requirements for Business Associate Contracts.
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(5) Do office staff members regularly change their passwords and safeguard
access to their work areas?
(6) Where are medical records and lab reports kept? If these documents are
disclosed, what is the policy and to whom may these documents be
disclosed?
(7) Are there safeguards that are documented regarding the transfer of PHI as
paper medical records, orders, images, and lab specimens?
(8) Is there an employee handbook or other human resources documentation that
can be expanded to cover HIPAA requirements?
(9) Are there documented policies and procedures when an employee is
terminated? Does this include the return of all keys, cards, and change codes
and locks, as necessary?
After generating an internal HIPAA compliance checklist and actually performing the
assessment, the organization needs to conduct a gap analysis. The gap analysis is a comprehensive
report that outlines the gap between the organization's current state ofprivacy and the required level
needed to meet HIPAA regulations. From this gap analysis, the organization can begin to develop
priorities, work plans, and budgets to meet the HIPAA mandate. Example Two illustrates how the
gap analysis works together with the HIPAA analysis questionnaire.
Example 2: HIPAA Gap Analysis
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HIPAA Requirement
(1) Authorization.
45 CFR §164.508(a)
Questionnaire
1. Does the organization use PHI for purposes other than
treatment, payment or health care operations?
Answer: Yes
2. If yes, how?
Answer: Marketing and Research
3. Does the organization obtain any form of authorization
prior to the use or disclosure?
Answer: No
4. If yes, before every use or disclosure?
Answer:
5. Is the authorization a form or is it individualized?
Answer:
6. Attach copy of any and all authorizations used.
Deficiencies
1. No policy
or procedure
for obtaining
authorizations
Solutions
1. Prior to
every
disclosure of
PHI
organization
needs to obtain
HIPAA
compliant
authorization.
2. Need written
policies and
procedures for
obtaining
authorization.
3. Need to
formulate
HIPAA
compliant
authorization to
be adapted and
used by
appropriate
personnel.
Resource
Estimate
&timated
attorney
hours to
complete:
&timated
cost:
:.:.:.:-:-:.:-:.:.;.:-:.:.:.:.:.:-:-:.:.:.:-:-:.:-:.:-:.:.:.:.:-:.:.:.:.:-:.:-:.:.:.:.:-:.:.:.:.:.:.:-:.:-:-:.:.:-:-:.:-:.:.:-:.:.:.:.:.:-:.:.:.:-:.:-:.:.:.:.: :- :-:.:.:.:-:-:.:.:-:-:.:-:.:-:-:.:-:.:-:.: ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::-:.
....
..
ID. Phase 3: Management Review
The management review phase is conducted once the assessment and gap analysis are
complete. Although in many practices "management" actually prepared or helped prepare the
assessment and gap analysis, this phase is still very important because it is at this point that
organizational consensus is gained and priorities are set. Failure to achieve consensus and organize
priorities may lead to problems that will hinder your organization's overall progress. This step is
essential in keeping your organization from being consumed with turfbattles and resource allocation
(or re-allocation) issues, instead of working toward HIPAA compliance.
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Phase Three should allow those in charge of HIPAA compliance to compile and present
compliance recommendations to management as well as back up the recommendations with factual
information (the risk assessment and gap analysis). If senior management has not been involved
with the assessment and gap analysis, it is their tum to provide direction and communicate priorities
which require action. At the end of phase· three, most, if not all, of the aspects of your workplan
should be identified. For example:
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Example 3: Workplan
HIPAA HIPAA Solution Whose Target Actual Target Task
Requirement Questionnaire Responsibility? Start Date Start Date End Date Status
Authorization 1. Does the 1. Prior to every Organization's 1/01/03 2/01/03
45CFR Practice use PHI disclosure of Attorney
§164.508(a) for purposes other PHI organization
than treatment, needs to obtain
payment or health HIPAA
care operations? compliant
authorization.
Answer: Yes 2. Need written
policies and
2. How? procedures for
obtaining
Answer: authorization.
Marketing and 3. Need to
Research formulate
HIPAA
3. Does the compliant
Practice obtain authorization to
any form of be adapted and
authorization used by
prior to the use or appropriate
disclosure? personnel.
Answer: No
IV. Phase 4: Compliance Implementation
Although your organization may perform an excellent job of assessing its current privacy
practices and determining what needs to be done, poor implementation of the necessary
improvements will have a detrimental impact on achieving HIPAA compliance. Phase Four is where
the planning and assessment activities end, and the implementation begins.
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It is in this phase where your organization must develop or refme its privacy practices,
policies and procedures. In addition to actually developing HIPAA-compliant consents,
authorizations, notice of information practices and business associate contracts, formal written
policies and procedures for all aspects of PHI privacy need to be created and implemented and
employees, staff and management need to be trained as to the new policies and procedures. This
phase will most likely need to be allotted the most time and resources.
Under the title of Administrative Requirements, the Privacy Rule requires that:
a covered entity must implement policies and procedures with respect to protected
health information that are designed to comply with the standards, implementation
specifications, or other requirements of this subpart. The policies and procedures
must be reasonably designed, taking into account the size ofand the type ofactivities
that relate to protected health information undertaken by the covered entity, to ensure
such compliance. 45 CPR. §164.503(i).
The Privacy Regulation also requires a covered entity to change its policies and procedures
when "necessary and appropriate" to comply with changes in the law and/or changes in the entity's
privacy practice.21 The documentation of policies and procedures may be either in written or
electronic form. 22 ~n addition, a covered entity must retain the documentation for six (6) years from
the date it was created or was last in effect whichever is later.23 Since the privacy rules are designed
to be flexible and scalable, larger, more technologically sophisticated entities are required to
implement more extensive and more stringent privacy policies and procedures. Although an entity's
decisions regarding the scope of its policies and procedures can be influenced by physical factors
2145 CPR §164.530(i)(2).
2245 CPR §164.530G)(l).
2345 CFR §164.530G)(2).
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such as size and by business factors such as acceptable levels of risk, please note that even the
smallest entity must implement the policies and procedures required to protect the PHI in its care.
It may be helpful at this stage for your organization to categorize the policies and procedures
required by the Privacy Rule. The fIrst category ofpolicies and procedures relate to a patient's rights
regarding the privacy of their PHI. The second category of policies and procedures is comprised of
governmental requirements concerning the protection of PHI. The following is an outline of the
policies and procedures, by category, which must be implemented and documented by all covered
entities.
I. Patient Rights:
(1) Notice of Privacy Practices for Confidential Information: The Privacy
Rule states that "an individual has a right to adequate notice of the uses and
disclosures of protected health inforamtion that may be made by the covered
entity, and of the individual rights and the covered entity's legal duties with
respect to protected health information.,,24 The elements required for a
HIPAA-compliant notice of privacy practices are found in the regulation at
45 CFR §164.520(b) and your organization's privacy policy must contain
every element. The policy manual must include a reference to the Notice and
procedures outlined in the manual must be consistent with the Notice,
including procedures for notifying patients of changes in the Notice.
(2) Access of Individuals to Confidential Information: Individuals have the
right to inspect and obtain a copy of their confidential information, for as
2445 CPR §164.520(a).
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long as the covered entity maintains the information. Covered entities must
have in place policies defming the following: 25
(A) To what confidential information individuals have access;
(B) Who can request the information;
(C) The procedures for requesting information;
(D) The time frames for responding to a request;
(E) When the covered entity can deny access; and
(F) How an individual may appeal a decision to deny access.
(3) Amendment of Confidential Information: An individual has a right to have
a covered entity amend confidential information about the individual so long
as the covered entity maintains the information. The written policies must
conform to the Privacy Rule requirements and must address:26
(A) The process for accepting a request for and making an amendment of
confidential information;27
(B) How quickly a covered entity must respond to an amendment request;28
(C) How to proceed if the originator of the information is no longer available; and
(D) The process for denying a request for amendment.29
25See 45 CPR §164.524.
26See 45 CPR §164.526.
27See 45 CPR §164.526(b)(1).
28See 45 CPR §164.526(b)(2).
29See 45 CPR §164.526(d)(1).
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(4) Accounting for Disclosures: Individuals have a right to receive an
accounting of all disclosures of confidential information. Disclosure
information must be made available for a six (6) year period. A record of
disclosure does not have to be made when those disclosures are:
(A) To carry out treatment, payment or health care operations;
(B) To individuals of confidential information about them;
(C) For the covered entity's directory or to persons involved in the individual's
care;
(D) For national security or intelligence purposes; or
(E) To correctional institutions or law enforcement personnel.
(5) Complaints to the Covered Entity: A covered entity must provide a process
for individuals to make complaints concerning the entity's policies and
procedures required under the privacy rule.30 The entity must:
(A) Have a procedure in place to document all complaints received, and their
disposition, if any; and
(B) Work to mitigate any problems known to· the entity.
(6) Waiver of Rights: A covered entity may not require an individual to waive
his/her rights under the privacy rule as a condition of the provision of
treatment.31
II. Government Requirements:
30See 45 CFR §164.530(d)(1).
31See 45 CPR §164.530(h)
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(1) Uses and Disclosures of Confidential Information: The policy manual
must reflect and be consistent with the Notice of Privacy Practices, the
Consent Form, and the Authorization Form. The policy manual must also
reflect and implement policies regarding the following:
(A) Fund Raising Restrictions;32
(B) Marketing Restrictions;33
(C) "Minimum Necessary" Provisions;34
(D) "De-Identification" of Confidential Information;35
(E) Exceptions to the requirement to obtain Consents or Authorizations;36
(F) Uses and Disclosures for when an Authorization is required;37 and
(G) Consent for uses and disclosures to carry out treatment, payment orhealth care
operations.38
(2) Business Associates: Before a covered entity may disclose confidential
information to a business associate, it must obtain satisfactory assurances that
the business associate will appropriately safeguard the information. The
assurances must be provided in a written contract or agreement that
3245 CFR §164.514(t)(l).
3345 CPR §164.514(e)(1).
3445 CPR §164.514(d)(1).
3545 CPR §164.514(a)-(b).
3645 CPR §164.512.
3745 CPR §164.508.
3845 CPR §164.506.
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documents the permitted and required uses and disclosures of confidential
information by the business associate. The contract between the covered
entity and the business associate must meet the explicit requirements set out
in the Privacy Rule at 45 CFR §164504(e)(2) or (e)(3).
(3) Mitigation: A covered entity must mitigate, to the extent practicable, any
harmful effect that is known to the entity ofa use or disclosure ofconfidential
information in violation of its policies or procedures or the requirements of
the rule or any of its business associates.39
(4) Refraining from Intimidating ·or Retaliatory Acts: A covered entity may
not intimidate, threaten, coerce, discriminate against, or take other retaliatory
action against individuals or others for any reason.40
(5) Ensuring Confidential Information is Secure: A covered entity must have
in place appropriate administrative, technical, and physical safeguards to
protect the privacy of confidential information.41
(6) Training: Covered entities must train all members of its workforce on the
policies and procedures with respect to confidential information, as necessary
and appropriate for each member of the workforce to carry out his/her
function within the entity.42 The training must:
39See 45 CPR §164.530(t).
40See 45 CFR §164.530(g).
41See 45 CPR §164.530(c).
42See 45 CFR §164.530(b).
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(A) be provided to each member of the workforce by no later than the compliance
date for the entity;
(B) be provided thereafter, to each new member of the workforce within a
reasonable period of time after the person joins the entity's workforce; and
(C) be provided to each member of the entity's workforce whose functions are
affected by a material change in the policies or procedures required by this
rule, within a reasonable period of time after the material change becomes
effective.
(7) Sanctions: A covered entity must have and apply appropriate sanctions
against members of its workforce who fail to comply with the privacy
policies and procedures of the entity and the requirements of the rule.43
43See 45 CPR §164.530(e).
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v. Phase 5: Troubleshooting and Auditing
After a covered entity fInishes the implementation process, the entity should provide itself
time to adjust to the new policies, procedures and administrative requirements of the HIPAA
regulations. The fmal compliance deadline is April, 2003 and any deviation from the requirements
after that point would be considered a violation of HIPAA. The penalties for a covered entity's
failure to abide by HIPAA's guidelines can mean harsh civil monetary and/or criminal penalties.44
The criminal penalties for violating the HIPAA privacy standards state:
a. Offense.-
A person who knowingly and in violation of this part-
(1) uses or causes to be used a unique health identifier;
(2) obtains individually identifiable health information relating to an individual; or
(3) discloses individually identifiable health information to another person,
shall be punished as provided in subsection (b).
b. Penalties.-
A person described in subsection (a) shall-
(1) be fined not more than $50,000, imprisoned not more than 1 year, or both;
(2) if the offense is committed under false pretenses, be fined not more than
$100,000, imprisoned not more than 5 years, or both; and
(3) if the offense is committed with intent to sell, transfer, or use individually
identifiable health information for commercial advantage, personal gain, or malicious
p;tnn, be fined not more than $250,000, imprisoned not more than 10 years, or both."
There are also civil penalties for violating HIPAA' s privacy guidelines. The civil penalties include
fines of $100 for each violation, up to a maximum of $25,000 for violating a particular requirement
of the law.46
44mPAA's enforcement provisions are found at 24 USC §§ 1320d-5 & 1320d-6
4542 USC §1320d-6.
4642 USC §1320d-5.
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In addition to initially making sure your organization complies with the Privacy Rule by
April 2003, the Privacy Rule also requires organizations to continually audit their compliance. The
continuing compliance responsibility of covered enitities, once an effective compliance plan is
implemented, requires the following of covered entities:
(1) Covered entities must keep records and reports documenting compliance;
(2) Covered enitities must cooperate with the Secretary of Health and Human
Services [hereinafter the "Secretary] if the Secretary decides to to review the
polices, procedures or practices of the covered entity; and
(3) Covered entities must pennit the Secretary access to its records and facilities
if the Secretary undertakes such a review.47
Conclusion
Undoubtedly HIPAA' s privacy provisions will drastically change how most covered entities
interract with eachother, with the government and with patients. The Privacy Rule requires that
these changes be documented. However, because the DHHS has not yet provided covered entities
with a model HIPAA privacy compliance plan, organization's must review the Privacy Rule
requirements and tailor a compliance plan to fit the organiation's individual needs. The five phases
4745 CPR § 160.310.
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identified in this paper should guide your organization through this process. Once the process is
complete, your compliance plan should contain at least the following elements:
(1) Privacy Officer designation;
(2) Documented and implemented privacy policies.
(3) Workforce training regarding the organization's privacy policies and .
procedures;
(4) Safeguards adopted to protect PHI;
(5) Complaint process established for privacy violations;
(6) Organizational ban on retaliation against individuals for privacy complaints;
(7) Sanctions for privacy violations;
(8) Organizational procedures to lessen the harmful effect of damage from
known privacy violations; and
(9) Organizational acknowledgement regarding an indivuals unwaivable right to
complain.
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.:. Compliance Deadline: October 16, 2002 
.:. "Administrative Simplification Compliance Act~ pushed compliance to October 16, 
2003 if you submit a compliance plan to HHS no later than October 16, 2002 . 
• :. Government's compliance form to be accessible by March 31, 2002 at: 
.:. http://www.aspe.hhs.gov/admnsimp/ 
.;. Helpful HIPAA websit,,: 
.:. http://www.hipaa·ig.com 
.:. http://www.hipaadvisory.com 
.:. Compliance plans must summarize the following: 
.:. An analysis reflecting the extent to which, and the reasons why, the entity is 
not in compliance; 
.:. A budget, schedule, work plan, and implementation strategy for achieving 
compliance; 
.:. Whether the entity plans to use or might use a contractor or other vendor to 
assist the entity in achieving compliance; and 
.:. A time frame for testing that begins no later than April 16, 2003. 
1 
.:. Covered entities that fail to submit compliance plans are required to comply with 
the electronic standards no later than the original deadline of October 16, 2002 . 
• :. failure to comply and/or submit a compliance plan may mean exclusion from 
Medicare in addition to all other penalties permissible under HIPAA . 
• :. DOES NOT affect the April 2003 compliance date for privacy. 
b- ,,' "',,'" " " .. '.,' 
.:. Eff"tive Date - April 14, 2001 
.:. Compliance Date - April 14, 2003 
.:. Appoint a privacy official and a privacy contact. 
~:. Develop, implement and document privacy policies and pracedurllS . 
• :. Train workforce on privacy . 
• :. Adllpl privacy safeguards for prolBcted health information • 
• :. £stablish a complaintpracess for privacy vio[ations • 
• :. Nil retaliation aUowed against individuals for privacy complaints . 
• :. Setsanctiornl for privacy violations . 
• :. lessen harmful effects of damage from known privacy violations . 
• :. No waiver of individual right to complain aUowed. 
2 
.:. Begin educating Board/Trustees and upper management about HIPAA compliance and its 
potentialirnpact. 
.:. Identify key individuals within the organization to form a HIPAA Steering Committee . 
• :. Appoint a privacy official. This person will oversee and coordinate training and compliance 
programs . 
• :. Become familiar with the privacy requirements and identify the types of information that are 
protected . 
• :. Review your state's applicable law. HIPAA is a baseline standard. Your state may require 
.:. Assessimpactonbudget. 
.:. BeginintemaJ risk assessment of business-consider engaging lega I counsel in order to 
invokeattomeylclientprivilege 
.:. Collect all existing privacy policies and procedures regarding the handling of and 
access to private health information . 
• :. Take inventory of data repositories where patient information is generated, stored, 
received or transmitted. Even palm pilots and personal computers may be 
repositories of PHI. Determine what PHI is collected, how it is maintained, who has 
access and how it is being used/disclosed . 
• :. Make risk assessments. What services do you provide? What types of PHI do you 
routinely handle? What privacy precautions do you currently have in place? 
.:. Begin working with legal counsel to develop basic HIPAA compliant business 
associate contracts and consent and authorization forms . 
• :. Prepare checklist as guidance by using Phase I list of HIPAA requirements . 
• :. Prepare GAP analysis in order to develop priorities, work plan'> and budgets . 
• :. Put together an organizational chart and have HIPAA Steering Committee members 
work with senior management to characterize types of business tines the 
orgamzation engages in and how Information flows in and out of the organization . 
• :. Prepare budgets to fund technological requirements, education, training and risk 
protection. 
3 
.:. Research: 
.:. Review research practices of the institution, IRB and individual resaarchers: 
·:·Schools 
·:·Oepartments 
":·Labs 
·:·Pmtocol·by·pmtocol 
.:. Decide whether IRB will also function as a Privacy Board . 
• :. If Privacy Board is used, coordinate its examination of protocols with the IRB . 
• :. Revise consent forms currently being used to take advantage of transition rules . 
.. :. Consent should specifically allow use/disclosure of subject's P HI for research 
purposes and for TPO . 
• :. Sit down with management in order to gain organizational consensus and set 
priorities . 
• : .. Prepare HIPAA compliance fonns including consent, authorization and business 
associate forms and develop notices regarding individual patients' privacy rights . 
• :. Begin developing a privacy compITance plan by establishing detailed, written privacy 
policies and procedures, making sure to reserve the right to revise the policies and 
procedures as needed due to changes in the law. 
4 
.:. Develop policies to ensure disclosure of the "minimum necessary" PHI as required 
by the final rule. Put in place procedures to deal with routine and recurring 
disclosures as well as a system to evaluate unique requests and disclosures. 
Personnel may be classified into groups according to the infonnation they handle, 
and types of information created . 
• :. Implement appropriate administrative, technical and physical safeguards to protect 
the privacy of PHI. 
.:. Develop and negotiate required business associate contracts with third parties that 
provide services to the covered entity . 
• :. Develop a policy and procedure mechanism to allow individuals to inspect and copy their PHI. 
.:. Train workforce on privacy policies and procedures; document thotra ining. Create 
education and communication programs for employees as a defensive measure to help 
minimize employee misunderstandings of patients' rights and avoid erroneous claims of 
privacy violations . 
• :. Develop record·keepingsystems to track and monitor access to and handling of protected 
information . 
• :. Create security agreements/affidavits fOTsignature hy employees h andnngprotected 
information . 
• :. Include HIPAA compliance in tho development of future husiness strategies . 
• :. Review all existing insurance policies with respect to coverage of inappropriateusesoT 
disclosures of health information . 
.. : .. Establish a system to report privacy complaints, including the dBlli gnation of a contact 
person Of offico that is responsible for receiving complaints and able to providefurthor 
information . 
• :. Develop quick response procedures to investigate potential privacy breaches . 
• :. Develop and apply disciplineproceduTos for individuals andbusi ness associates who are 
found to have breachod policies. 
5 
I ... 
• :. Mitigate, to the extent possible, the hannful effects of the inappropriate disclosure 
of PHI known to the covered entity or its business associates . 
• :. Implement a process for the ongoing auditing and monitoring of the organization's 
privacy initiative and workforce training program. 
4:. leave a period of time in order to adjust to new policies and procedures and to 
make adjustments. 
Penalties for violations: 
.:. No private cause of action . 
• :. Civil or criminal penalties possible . 
• :. Civil: $100 per violation up to $25,000 per person, per year for each 
negligent violation. 
·:·Criminal: penalties from $50,000· $250,000 and 1 to 10 years in prison 
can be imposed for knowingly violating the Act. 
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Dennis P. Kennedy
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SECTIONF

Amendment of Protected Health
Information
45 CFR 164.526
1 Standard: The Right to Amend
5 Implementation Specifications
1) Requests and timely action
2) Accepting the amendment
3) Denying the amendment
4) Actions on notice of amendment
5) Documentation
Standard: The Right to Amend
• Right to Amend
- As long as PHI is maintained in the designated record
set
• Denial of Amendment (4 grounds)
1) PHI not created by Covered Entity
2) PHI not part of the designated record set
3) PHI not available for inspection under 164.524
4) PHI is accurate and complete
Requests for Amendment
• Individual's Request
- Covered Entity must allow requests
- Covered Entity may require written requests for
amendment to be made in writing
Deters, Benzinger & LaVelle, P.S.C.
2701 Turkeyfoot Road
Covington, KY 41017
(859) 341-1881
F -I
Timely Action
• Covered Entity must act within 60 days if:
- Amendment grcmted, take action;
- Amendment denied, provide notice
• If unable, extend for 30 days
- Provide:
• Reasons for delay;
• Date by which Covered Entity will complete its action on the
request;
• Only one extension permitted
Accepting the Amendment
If amendment is accepted
1) Either append or provide a link to the
amendment.
2) Inform the individual
3) Inform others
Denying the Amendment
5 Components to the Denial
1) The denial
2) Statement of disagreement
3) Rebuttal statement
4) Recordkeeping
5) Future disclosures
Deters, Benzinger & LaVelle, P.S.C.
2701 Turkeyfoot Road
Covington, KY 41017
(859) 341-1881
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Denial
• Timely denial must be provided (60 days)
-In writing
- Plain language
- Basis for denial
- A statement regarding future disclosures
- A description of the complaint process under
164.530
Statement of Disagreement
• Individual must be allowed to submit a
written statement of disagreement
• Covered Entity may limit the length
Rebuttal Statement
• Covered Entity may prepare in response to
individual's statement of disagreement
• Provide a copy to the individual
Deters, Benzinger & LaVelle, P.S.C.
2701 Turkeyfoot Road
Covington, KY 41017
(859) 341-1881
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Recordkeeping
• Identify the record or PHI subject to
disagreement
• Append or link the correspondence
regarding the amendment to the designated
record set
Future Disclosures
• If a statement of disagreement has been submitted:
- Covered Entity must include the request and its denial
(or a summary of such information) with any
subsequent disclosure
• If no statement of disagreement has been
submitted:
- A Covered Entity is required to provide such
information upon further disclosure only if individual
requested such action.
Actions on Notices of
Amendment
• A Covered Entity informed by another
Covered Entity of an amendment must
amend the PHI
Deters, Benzinger & LaVelle, P.S.C.
2701 Turkeyfoot Road
Covington, KY 41017
(859) 341-1881
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Documentation
• Document titles of persons or offices
responsible for receiving and processing
requests for amendments
• Retain documentation
Questions & Answers
Deters, Benzinger & LaVelle, P.S.C.
2701 Turkeyfoot Road
Covington, KY 41017
(859) 341-1881
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BUSINESS ASSOCIATES
Carole D. Christian, Esq.
Wyatt, Tarrant & Combs, LLP
Suite 2700, PNC Plaza
500 West Jefferson Street
Louisville, Kentucky 40202
(502) 562-7588
I. Permissive Use of PHI: A Covered Entity may:
(1) Disclose protected health information ("PHI") to a business associate and
(2) Allow a business associate to create or receive PHI on its behalf
if the Covered Entity obtains satisfactory assurance that the business associate will safeguard the
information. 45 CFR § 164.502 (e)(l).
II. Definition of Business Associate: (45 CFR § 160.103) With respect to or on behalf of a
Covered Entity, but excluding members in the workforce of the Covered Entity, a person
who:
[A] performs or assists in the performance of a function or activity involving the
use or disclosure of individually identifiable health information.
Examples include:
• claims processing or administration
• data analysis
• utilization review
• quality assurance
• billing
• benefit management
• practice management
• repricing
• any other activity regulated by HIPAA
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[B] provides any of the following specifically listed services to or for a
Covered Entity if the service involves the disclosure of individually
identifiable health information by the Covered Entity or another
Business Associate.
• legal services
• actuarial services
• administrative Services
• accounting Services
• management Services
• consulting Services
• data aggregation (defined in 45 CFR § 164.501)
• financial services
• accreditation
A Covered Entity may also be a Business Associate of another Covered Entity.
m. Exclusions from Definition. Requirement for a written agreement does not apply to:
[A] Disclosures by a Covered Entity to a health care provider concerning the
treatment of an individual.
[B] Disclosures by a group health plan or a health insurance issuer or HMO with
respect to a group health plan to the plan sponsor, as long as the plan
documents properly restrict such disclosures (see 45 CFR § 164.504).
[C] Disclosures to members of Covered Entity's workforce, "Workforce" means
employees, volunteers, trainees and others whose work is under the "direct
control" of the Covered Entity, whether or not paid. "Direct Control"
requirement may exclude independent contractors and board members. (45
CFR § 160.103).
[D] Entities that perform services as part of an "organized health care
arrangement," i.e., clinically integrated setting in which patients receive care
from multiple health care providers.
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[E) Entities that are merely conduits for information (e.g., U.S. Postal Service,
electronic equivalents, couriers)
[F) A financial institution that is engaged in authorizing, processing, clearing,
settling, billing, transferring, reconciling or collecting payments, e.g. credit
card payment processing, check clearing, processing electronic funds transfer.
(Distinguish from an institution operating an accounts payable system or
other "back office" function on behalf of provider.)
IV. Required Assurances. 45 CFR § 164.504. Except in a few instances in which "other
arrangements" are authorized (see below), a Covered Entity must enter into a written contract
with a Business Associate in order to document satisfactory assurances that health
information will be protected.
A. Written contracts must:
[1] Establish the permitted and required uses and disclosures ofsuch information
by the Business Associate. Disclosures can be identified by type or purpose.
Note: Preamble states that covered entities may rely on the professional
judgment of their business associates as to the type and amount of protected
health information that is necessary to carry out a permitted activity.
[2] Authorize termination if the Covered Entity determines that the Business
Associate has violated a material term of the contract, unless such termination
is inconsistent with statutory obligations of either party.
[3] Provide that the Business Associate will:
[a] not use or disclose the information except as permitted by the contract
or as required by law;
[b) use appropriate safeguards to prevent unpermitted use or disclosure of
the information;
[c) report to the Covered Entity any use or disclosure of the information
not allowed for by the contract of which the Business Associate
becomes aware;
[d] ensure that any agent or subcontractor of the Business Associate who
receives or creates protected health information on behalf of the
Covered Entity agrees to the same contractual restrictions.
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[e] honor the right of access by an individual to his own records upon
request (see, 45 CFR § 164.524)
[f] make available protected health information for amendment and
incorporate amendments into record (~, 45 CFR § 164.526)
[g] make available information required to provide an accounting of
disclosures (see, 45 CFR § 164.528)
[h] make its internal practices, books, and records received from or
created for the Covered Entity available to the Secretary for the
purpose of determining the Covered Entity's compliance
[i] return or destroy all protected health information belonging to the
.Covered Entity at the termination of the contract, if feasible, or, ifnot,
extend life of the contract and limit further uses and disclosures to
necessary use.
B. Written Contracts May allow for uses by the Business Associate for the proper
management and administration of the Business Associate or to carry out its legal responsibilities. It
may allow for disclosures by the Business Associate (acting as a Business Associate) for the same
purposes ifdisclosure is required by law; or if the Business Associate obtains reasonable assurances
that the recipient will protect confidentiality and the recipient is required to notify the Business
Associate of any breach. 45 c.F.R. 164.504(e)(4).
C. Other Assurances: If the Covered Entity and Business Associate are both
governmental entities, they may enter a "Memorandum of Understanding" instead of contract.
Alternatively, the Covered Entity may be governed by other laws (including promulgated
regulations) that achieve the same objectives.
D. Legally Required Business Associate Action. If a Business Associate is required by
law to perform a service on behalfof a Covered Entity, the Covered Entity may disclose information
necessary to meet the legal requirement without giving assurances, if it documents inability to obtain
satisfactory assurances from Business Associate in spite of good faith efforts.
V. Measuring Compliance.
A Covered Entity is noncompliant with the regulations if the Covered Entity knew of a
pattern of activity or practice of the Business Associate that violated the contract, unless the Covered
Entity took action to cure the breach. 45 CFR § 164.504(e).
"Knowledge" is not defined in the regulation but the preamble suggests it is triggered by
"substantial and credible evidence."
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If actions to cure the Business Associate's breach are unsuccessful the Covered Entity must:
[1] if feasible, terminate the contract
[2] if not feasible, report the problem to the Secretary. Feasibility is
tested by whether there are viable alternatives, not whether other
options are less convenient or more costly.
VI. Changes from Proposed Rule (see 65 Fed. Reg. 82503 to 82507; (Dec. 28, 2000».
A. "Business Associate" instead of "Business Partner."
B. No third-party beneficiary language.
C. Expanded ability to disclose PHI for treatment purposes (rather than limitation to
consultation or referral).
D. Excludes disclosure by group health plan satisfying 45 CFR § 164.504(f) to plan
sponsor.
E. Reduced monitoring of Business Associates. "Reasonable steps to ensure"
compliance removed; now focus is on curing breach.
F. Termination following violation required only "if feasible."
G. Permits "data aggregation" by Business Associate using data from multiple Covered
Entities.
VII. Optional Contract Provisions to Consider:
• Detail concerning permissible uses, security and access controls
• Provision for Covered Entity to inspect records, security controls
• Procedures for Business Associate and Covered Entity to follow in event of request
by individual for access or amendment
• Appendix for Business Associate to use in contracting with other entities
• Provisions for segregation of PHI in records of Business Associate
• Method of reporting known violations..
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• Detail concerning Covered Entity's rights to enforce cure in event of breach
• Methods for Business Associate's disposal of information
• Indemnification provisions; Business Associate may want to consider getting
subcontractor to indemnify for loss of Covered Entity's business due to violation.
• Coverage of Covered Entity as named insured on Business Associate's policies
• Effect of changes making law more onerous; necessity for new agreement
• "Placeholder provisions" - right to require a contract in the event contractor of
uncertain status is deemed to be Business Associate
Vill. Covered Entity Planning Concerns.
A. Timing - Contracts being renewed now may not be reviewed again until after
effective date
- Business Associate identification will affect other compliance, e.g.
scope of authorization forms
B. Contractors Without Written Contracts
- May hamper identification
- Getting contract executed may be a change in the culture of relationship, take time
C. Contract Cross-Referencing, e.g., Stark IT requirement that contracts between parties
to personal services arrangements be in same document or cross-reference each other.
D. Monitoring Business Associates - What affirmative duties should privacy officer
have?
- How to capture "Knowledge" of violation by employees who don't
have a direct compliance function
E. "Whistle blowers" - Preamble notes that Business Associate may be a whistle blower
on Covered Entity even though Business Associate is not directly required to correct
violations.
IX. "Chain of Trust Agreement" - The proposed rules for Security and Electronic Signature
Standards, 63 Fed. Reg 43241 (August 12,2998) would require health plans and covered health care
clearinghouses (i.e., those entities covered in proposed rule 45 CPR § 142.302) who transmit
information to other persons electronically to have in place agreements in which both sender and
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recipient agree to protect the integrity and confidentiality of the data. See also, definition of "Chain
of Trust Partner Agreement" in Glossary, 63 Fed. Reg. 43272 (August 12, 1998).
Scope of terms "Business Associate" and "Chain of Trust Partner" will overlap
Little guidance available yet on Chain of Trust Agreements.
Recommend requirement to comply with terms applicable to Chain of Trust partners
in any Business Associate agreements entered now, if information will be exchanged
electronicaily.
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SAMPLE BUSINESS ASSOCIATE AGREEMENT
proposed by Wyatt, Tarrant & Combs, LLP
Suite 2700, PNC Plaza
500 West Jefferson Street
Louisville, Kentucky 40202
(502) 589-5235
This Agreement is entered into on this
__________ and _
day of __, 2002, between
WHEREAS, is a "covered entity" under the Health Insurance
Portability and Accountability Act of 1996 ("HIPAA") and any regulations promulgated thereunder or any
amendment thereof;
WHEREAS, the parties' existing business relationship requires to
disclose to , information that is confidential and must be afforded special
treatment and protection in accordance with HIPAA, and the regulations promulgated thereunder at 45
CFR Parts 160 and 164;
NOW, THEREFORE, the parties agree as follows:
Section 1. Definitions. The following terms shall have the meaning ascribed to them in this Section.
a. Business Associate shall refer to _
b. Covered Entity shall refer to _
c. HIPAA Privacy Regulations shall mean the Code of Federal Regulations (C.F.R.) at
Title 45, Parts 160 and 164.
d. Protected Health Information or "PHI" shall means any information, whether oral or
recorded in any form or medium (i) that relates to the past, present or future physical
or mental condition of an individual; the provision of health care to an individual; or
the past, present or future payment for the provision of health care to an individual,
and (ii) that identifies the individual or with respect to which there is a reasonable
basis to believe the information can be used to identify the individual, and shall have
the meaning given to such term found at 45 c.F.R. § 164.501.
e. Parties shall mean Business Associate and Covered Entity.
f Secretary shall mean the Secretary of the Department for Health and Human
Services ("HHS") and any other officer or employee of HHS to whom the
authority involved has been delegated.
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Section 2. Business Associate's Rights and Obligations:
The Parties anticipate that, during the term of this Agreement, Business Associate will
provide [DESCRIBE SERVICES TO BE PROVIDED BY BUSINESS ASSOCIATE]
Business Associate hereby agrees that it shall be prohibited from using or disclosing any PHI
provided or made available to it by Covered Entity for any purpose other than the following
[LIST PERMISSIBLE USES AND DISCLOSURES; MAY BE LISTED BY TYPE OR
PURPOSE]
a. Permitted Uses and Disclosures. [Optional] In addition to the foregoing, Business
Associate may use and/or disclose PHI provided or made available from Covered
Entity as follows:
(1) Business Associate may provide data aggregation services relating to the
health care operations of Covered Entity to Covered Entity;
(2) Business Associate may use or disclose PHI received by Business Associate in
its capacity as a business associate to Covered Entity, if necessary (i)for the
proper management and administration of Business Associate; or (ii) to carry
out the legal responsibilities of Business Associate; provided, however, that
Business Associate may disclose PHI for such purposes only if the disclosure
is made in its capacity as a Business Associate and: (i) the disclosure is
required by law; or (ii) Business Associate obtains reasonable assurances from
the person to whom PHI is disclosed that [A] the PHI will be held
confidentially and used or further disclosed only as required by law or for the
purpose for which it was disclosed; [B] the person will use appropriate
safeguards to prevent use or disclosure of the information; and [C] the person
will notify Business Associate of any instances of which it is aware that the
confidentiality of the PHI has been breached.
b. Obligations. Without limiting the obligations of Business Associate under this
Agreement or imposed by law, Business Associate agrees to comply with the
HIPAA Privacy Regulations as they apply to this Agreement. Specifically,
Business Associate shall:
(1) Not use or further disclose PHI disclosed to Business Associate by Covered
Entity other than as permitted or as required by this Agreement or as required
by law;
(2) Establish and maintain safeguards, including protection of the physical
security of any records and electronic access to any computerized records, to
prevent the use or disclosure of PHI, other than as provided for by this
Agreement;
(3) Immediately report to Covered Entity any use or disclosure of PHI not allowed
by this Agreement of which Business Associate becomes aware. In addition,
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Section 3.
Business Associate shall take prompt corrective action to mitigate the effect of
any unauthorized use or disclosure and to prevent recurrence.
(4) Ensure that any agents, including subcontractors, to whom Business Associate
provides PHI received from, or created or received by Business Associate on
behalf of, Covered Entity, enter a written agreement containing the same
restrictions and conditions that apply to Business Associate with respect to
PHI;
(5) Make PHI available: [A] to the individual whose PHI is at issue, in accordance
with 45 c.F.R. § 164.524, as amended; [B] for amendment, and incorporate
any amendments to PHI, in accordance with 45 c.F.R. § 164.526, as amended;
and [C] to the extent it is required to provide an accounting of disclosures in
accordance with 45 C.F.R. § 164.528, as amended; and
(6) Make Business Associate's internal practices, books, and records relating to
the use and disclosure of PHI received from, or created or received by,
Business Associate on behalf of Covered Entity, available to the Secretary for
the purpose of determining Covered Entity's compliance with the HIPAA and
HIPAA Privacy Regulations promulgated thereunder or any amendments
thereof.
Amendment. The Parties acknowledge that the HIPAA Privacy Regulations may be
modified from time to time. The Parties specifically agree to take such action as
necessary to implement the standards and requirements of HIPAA, HIPAA Privacy
Regulations and other applicable laws relating to the security and confidentiality of PHI.
Upon Covered Entity's request, Business Associate agrees to promptly enter into
negotiations with Covered Entity concerning the terms of an amendment to this
Agreement embodying written assurances consistent with the standards and requirements
of HIPAA, HIPAA privacy regulations or other applicable law. Covered Entity may
terminate this agreement and any other agreements between the parties upon [30] days'
written notice in the event (i) Business Associate does not promptly enter into
negotiations to amend this Agreement when requested by Covered Entity pursuant to this
section, or (ii) Business Associate does not enter into an amendment to this Agreement
providing assurances regarding the safeguarding of PHI that Covered Entity, in its sole
discretion, deems sufficient to satisfy the standards and requirements of HIPAA or the
HIPAA Privacy Regulations. Nothing herein shall be deemed to extend the term of any
other Agreement between the parites.
[Alternative: The parties acknowledge that the HIPAA Privacy Regulations may be
modified from time to time and that Covered Entity may be required by law to amend this
Agreement as a condition of doing business with Business Associate. In the event of any
amendments to HIPAA or the Privacy Regulations, Business Associate acknowledges
that Covered Entity may notify it, in writing, of required additional terms that Covered
Entity believes are necessary to amend this Agreement. Such terms shall amend and
become part of this Agreement unless Business Associate objects, in writing, to the notice
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Section 5.
provided by Covered Entity within thirty (30) days. In the event of such objection, the
parties shall negotiate diligently and in good faith a mutually agreeable amendment to this
Agreement. If the parties cannot reach agreement and Covered Entity reasonably
determines that this Agreement without amendment will not satisfy its obligations under
law, it may terminate the parties' relationship on thirty (30) days' written notice, except
that nothing herein shall be deemed to extend the term of any other agreements between
the parties].
Termination.
a. Material Breach. Business Associate agrees that Covered Entity may terminate
this Agreement, and any other agreements between the parties that require the
disclosure of PHI, immediately if Covered Entity determines that Business
Associate has violated a material term of this Agreement.
b. Reasonable Steps to Cure Breach. Alternatively, if Covered Entity learns of an
activity or practice of BusinessAssociate that could constitute a material breach
or violation of its obligations under this Agreement, Covered Entity may make a
demand that Business Associate take reasonable steps to cure such breach or end
such violation, as applicable. If Business Associate fails to cure such breach or
end such violation within thirty (30) days of notice, Covered Entity shall either:
(i) terminate this Agreement and any other agreements between the parties
requiring the disclosure of PHI, if feasible for Covered Entity, or (ii) if
termination of this Agreement is not feasible, Covered Entity shall report Business
Associate's breach or violation to the Secretary.
c Effect ofTermination. Upon termination of the Agreement, for any reason,
Business Associate shall return or destroy all PHI received from, or created and
received by Business Associate on behalf of Covered Entity. Business Associate
agrees not to retain copies of the PHI after termination of this Agreement. If
return or destruction of the PHI is not feasible, Business Associate agrees to
extend the protections of this Agreement for as long as necessary to protect the
PHI, but Business Associate shall not use or disclose PHI except for the limited
purposes for which extended retention of such records is necessary. If Business
Associate elects to destroy the PHI, it shall certify to Covered Entity that the PHI
has been destroyed.
Indemnification. [Optional] Each Party will indemnify, hold harmless and defend the
other party to this Agreement from and against any and all claims, losses, liabilities, costs,
and other expenses incurred as a result of, or arising directly or indirectly out of or in
connection with: (i) any misrepresentation, breach, or non-fulfillment of any undertaking
on the part of the Party under this Agreement; and (ii) any claims, demands, awards,
judgements, actions and proceedings made by any person or organization arising out of or
in any way connected with the Party's performance under this Agreement.
G -12
Section 6 Binding Nature and Assignment. This Agreement shall be binding on the Parties and
their successors and assigns, but neither Party may assign this Agreement without the prior written
consent of the other, which consent shall not be unreasonably withheld.
Section 7. Intemretation. This Agreement shall be interpreted as broadly as necessary to implement
and comply with HIPAA, the HIPAA Privacy Regulations and applicable state laws. The Parties agree
that any ambiguity shall be resolved in favor of a meaning that complies and is consistent with HIPAA
and the HIPAA Privacy Regulations.
IN WITNESS WHEREOF, Business Associate and Covered Entity have caused this
Amendment to be signed and delivered by their duly authorized representatives, as of the date set forth
above.
BUSINESS ASSOCIATE
BY:
ITS:
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COVERED ENTITY
BY:
ITS:
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Stites & Harbison PLLC
Lexington, Kentucky
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1. DEFINmONS OF KEY TERMS
(a) Covered Entity: Health plans; health care clearinghouses; and health care
providers who transmit any health information in electronic form in connection
with a covered transaction.
(b) Healthcare Operations: "any of the following activities of the covered entity to
the extent that the activities are related to covered functions ... (1) conducting
quality assessment and improvement activities ... (2) reviewing the competence
or qualifications of health care professionals, evaluating practitioner and
provider performance ... accreditation, certification, licensing, or credentialing
activities; (3) underwriting, premium rating, and other activities relating to the
creation, renewal or replacement of a contract of health insurance ... (4)
conducting or arranging for medical review, legal services, and auditing
functions, including fraud and abuse detection and compliance programs; (5)
business planning and development ... and (6) business management and
general administrative activities of the entity, including, but not limited to ...
fundraising for the benefit of the covered entity, and marketing for which an individual
authorization is not required as described in § 164.514(a)(2)." 42 CF.R. § 164.501.
(c) Protected Health Information: generally "means individually identifiable health
information! "that is transmitted by electronic media ... or transmitted or
maintained in any other form or medium." 42 CF.R. § 164.501.
2. BACKGROUND ON HIPAA PRIVACY RULES AND CONSENT AND
AUTHORIZATION REQUIREMENTS
(a) Basic HIPAA Privacy Requirement
The basic requirement of the final privacy rules (" Privacy Rules") is simply
stated as follows: /IA covered entity may not "use" or"disclose" [both terms broadly defined]
an individual's protected health information, except as otherwise permitted or required by this
subpart." 42 CF.R. § 164.502(a). Fully understanding the definitions of who (covered entity)
! "Individually identifiable health information" is defined as health information "including
demographic information collected from an individual, and: (1) Is created or received by a
health care provider, health plan, employer, or health care clearinghouse; and (2) Relates to the
past, present, or future physical or mental health or condition of an individual; the provision of
health care to an individual; or the past, present, or future payment for the provision of health
care to an individual; and (i) That identifies the individual; or (ii) With respect to which there is
a reasonable basis to believe the information can be used to identify the individual." 42 CF.R. §
164.501.
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and what (protected health information) are covered is the first step to being able to comply
with this complex regulatory mandate
(b) Permitted Uses and Disclosures
A health care provider is permitted to use and disclose protected health
information only as follows:
(i) To the individual who is the subject of the protected health information;
(ii) In compliance with the consent or authorization provided by the
individual;
(iii) Without the consent or authorization of the individual, if not required
under the rules;
(iv) Pursuant to an agreement with the individual under §164.510 which only
requires that the individual have an opportunity to agree or object.
(c) Consents
The final Privacy Rules require a "consent" for uses and disclosures of protected
health information for purposes of treatment, payment, and health care operations. Health care
providers and other covered entities must obtain a separate "authorization" (discussed below)
from the individual to use and disclose protected health information for other purposes. While
the terms "consent" and "authorization" have often been used interchangeably in the health
care context, they are defined terms under the Privacy Rules and differ substantially in their
content. A "consent" is written in general terms and allows a health care provider to use or
disclose protected health information only for treatment, payment, or health care operations
purposes. There are a few minor exceptions to this general rule. For example, health care
providers may use or disclose protected health information without a consent (1) in an
emergency, (2) if required by law, (3) if the patient is an inmate, (4) or if the provider has an
indirect treatment relationship with the patient.
(d) Authorizations
Unless an exception applies, a provider must obtain a patient's authorization to
use or disclose protected health information for any reason other than treatment, payment, or
healthcare operations. For example, if a provider wants to request protected health information
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from another provider, the patient must first sign a valid "authorization" form. While the
request may be for the purpose of treatment, a consent form only covers "uses and disclosures"
of patient information created by that particular provider. See 65 Fed. Reg. 82,511.
Providers generally cannot condition treatment on a patient's signing of an
authorization. Authorizations must be written in specific terms and are only valid if they
contain the specific elements set out in the Privacy Rules. Therefore, most handwritten patient
authorizations to release records will be invalid under the new rules as they will not contain an
expiration date or a statement about the individual's right to revoke the authorization.
(e) Consent or Authorization?
Consent Authorization
Purpose: To carry out Treatment, Payment, Purpose: To use or disclose protected health
and Healthcare Operations ("TPO"). information for purposes other than TPO.
Exceptions: Inclusion: A consent for uses and disclosures
1. Indirect treatment relation, of protected health information is required for
2. For inmates, TPO. For use and disclosure beyond TPO, a
3. In emergency treatment situations, specific authorization is required.
4. If required by law to treat an individual,
and where there are substantial
communication barriers.
(Attempt made to obtain consent and reason
why consent was not obtained should be
documented.)
Conditioning: Provider may condition Conditioning: A provider may not condition
treatment on provision of consent. treatment or payment on an authorization
except for research-related treatment and
when the disclosure is necessary to determine
payment of a claim.
Combination: Combination: An authorization may not be
1. A consent may not be combined with the combined with any other document except:
Notice of Privacy Practices. A consent 1. An authorization for protected health
may be combined with other types of legal information created for research that
permissions (e.g., informed consent for includes treatment of the individual;
treatment) if it is visually and 2. An authorization for the use or disclosure of
organizationally separate from the other psychotherapy notes may only be combined
permission, is separately signed. with another authorization for the use or
2. Where there are conflicting consents, the disclosure of psychotherapy notes; or
more restrictive applies. Provider may 3. An authorization may be combined with
attempt to resolve the conflict with a new another authorization when the provision of
consent or obtaining the individual's treatment or payment has not been
designated preference. conditioned on the provision of one of the
authorizations.
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Consent
Expiration: None
Retention: Signed consent forms must be
retained for six years.
Content requirements:
1. Inform individual in plain language of that
protected health information may be used
and disclosed for TPO,
2. Refer individual to Notice of Privacy
Practices for more complete information
and state that the individual has the right
to review the Notice prior to signing the
Consent,
3. State terms of Notice may change, if
applicable, and describe how the
individual may obtain a revised Notice,
4. State that individual has right to request
restrictions but covered entity is not
required to agree with request but if it
does so, must abide by request,
5. State that the individual has the right to
revoke the consent except to the extent that
action has already been taken, and
6. Be signed and dated by the individual.
Defective consents: Are not valid and are
those lacking any element of the content
requirements.
Authorization
Expiration: Date or event that relates to the
individual or purpose of use required. If
expiration date not provided for, then
authorization is defective.
Retention: Signed authorizations must be
retained for six years.
Content requirements:
1. Description in plain language of
information to be used or disclosed that
identifies the information in a specific and
meaningful fashion,
2. Name or other identification of person or
class of persons authorized to make the
requested use or disclosure or to whom the
provider may make the requested use or
disclosure,
3. An expiration date or event,
4. A statement of the individual's right to and
description of how to revoke the
authorization,
5. A statement that information may be
subject to redisclosure by the recipient and
no longer be protected by the rule,
6. Signature and date, and (if signed by a
personal representative) a description of
representative's authority.
Defective consents: Expiration date that has
passed, is incomplete, has been revoked, lacks
a required element, or contains information
known to be false.
Additional requirements: Specific to whether
the authorization is for the provider to request
information, others are requesting information
from the provider, or the authorization is for
research related to treatment.
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3. MARKETING
In the proposed privacy regulations issued in November 1999, the Department of Health
and Human Services (the "Department" or "HHS") would have required covered entities (i.e.
health care providers, health plans, and health care clearinghouses) to have obtained an
individual's "authorization2" prior to using or disclosing "protected health information" to
market items and services. The final Privacy Rule is less restrictive, yet more complex.
The Privacy Rule establishes a general rule (subject to a few exceptions) that covered
entities must obtain an individual's authorization before using or disclosing health information
for marketing. 42 C.F.R. § 164.514(e). The term "marketing" is now defined and specifically
excludes certain activities from its scope. The excepted activities are encompassed by the
definitions of treatment, payment and health care operations. Covered entities, may therefore,
use and disclose protected health information for these excepted activities pursuant to a general
consent under 42 c.F.R. § 164.506 if required, rather than an authorization under 42 c.F.R. §
164.508. See 65 Fed. Reg. 82,462, 82,493 (Dec. 28,2000).
(a) Definition of Marketing and Exceptions: 42 c.F.R. §164.501
"Marketing" is a "communication about a product or service a purpose of which
is to encourage recipients of the communication to purchase or use the product or service." 42
C.F.R. § 164.501. It is important to note that if a covered entity receives direct or indirect
remuneration from a third party for making a written communication, then the communication
is not excluded from the definition of marketing. By definition, the following communications
by a covered entity (which would otherwise meet the general definition of marketing) are not
deemed marketing so long as they are either (1) made orally or (2) made in writing if the covered
entity does not receive direct or indirect remuneration from a third party for making the
communication:
(1) Communications by a covered entity for the purpose of describing
the entities participating in a health care provider network;
(2) Communications by a covered entity for the purpose of describing
if and the extent to which a product or service (or payment for
such product or service) is provided by a covered entity or
included in a plan of benefits;
2 See discussion supra at Part 2; 42 C.F.R. § 164.508.
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(3) Communications by a covered entity that are tailored to the
circumstances of a particular individual and the communications
are made by a health care provider or health plan to an individual
as part of the treatment of the individual and for the purpose of
furthering the treatment of the individual; OR
(4) Communications by a covered entity that are tailored to the
circumstances of a particular individual and the communications
are made by a health care provider or health plan to an individual
in the course of managing the treatment of that individual, or for
the purpose of directing or recommending to that individual
alternative treatments, therapies, health care providers, or settings
of care.
The Department explains that these exceptions express their intent "not to interfere with
communications made to individuals about their health benefits .... [and] their treatment."
65 Fed. Reg. 82,493. The first two exceptions permit health plans to inform enrollees about
which doctors and hospitals are preferred providers and are included in its network; about
which providers offer a particular service; and that a new pharmacy has begun to accept its
drug coverage. The third exception permits a provider to recommend specific brand-name or
over-the-counter pharmaceuticals and to refer patients to other providers. The fourth exception
permits a provider to send reminder notices for appointments, annual exams.and prescription
refills or to inform a smoker about an effective smoking-cessation program, even if that
program is offered by someone other than the provider making the recommendation. See Office
of Civil Rights, Health-Related Communications and Marketing Guidance at
http://www.hhs.gov/ocr/hipaa/marketing.html Guly 6, 2001).
(b) Marketing Rules: 42.C.F.R. § 164.514(e)
(i) General Rule:
A covered entity may not use or disclose protected health information for
marketing without an authorization. § 164.514(e)(1). For example, a hospital or other provider
may not provide patient lists to pharmaceutical companies for those companies' drug
promotions without an authorization from each patient on the list. HHS assumes that the
"requirement for obtaining authorizations for use or disclosure of protected health information
for most marketing activity will make direct third-party marketing more difficult because
covered entities may not want to obtain and track such authorizations, or they may obtain too
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few to make the effort economically worthwhile." 65 Fed. Reg. 82,771.
(ii) Exceptions from Authorization Requirement
(1) Marketing communications that occur in a face-to-face encounter
with the individual (e.g. sample products may be provided to a
patient during an office visit);
(2) Marketing communications that concern products or services of
nominal value (e.g. a provider can distribute pens, toothbrushes or
key chains with the name of the covered entity or a health care
product manufacturer on it); OR
(3) Marketing communications that concern the health-related products
and services of the covered entity or of a third party, but only if the
communication:
a. Identifies the covered entity that is making the
communication;
b. Prominently states that the covered entity is receiving
direct or indirect remuneration for making the
communication, if applicable;
c. Except in the case of a general communication (e.g.
newsletter), tells individuals how to opt-out of further
marketing communications. The covered entity must
make reasonable efforts to honor requests to opt-out;
d. Explains why individuals with specific conditions or
characteristics (e.g. diabetics, smokers) have been targeted,
if that is so, and how the product or service relates to the
health of the individual. The covered entity must make a
determination prior to making the communication that the
product or service being marketed may be beneficial to the
health of the type or class of individual targeted.
HHS clearly contemplates the final Privacy Rule permitting"an alternative
arrangement: the covered entity can engage in health-related marketing on behalf of a third
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party, presumably for a fee. Moreover, the covered entity could retain another party, through a
business associate relationship, to conduct the actual health-related marketing, such as mailings
or telemarketing, under the covered entity's name." 65 Fed. Reg. 82,771.
(c) Business Associates
(i) Business Associates in General
A Business Associate relationship arises when the right to use or disclose
protected health information belongs to the "covered entity" (e.g. health care provider) and
another person is using or disclosing that information to perform a function on behalf of, or to
provide services to, that covered entity. Examples of business associates are firms conducting
claims processing or administration; data analysis; utilization review; quality assurance; billing;
practice management; or legal, accounting, management, administrative, accreditation, or
financial services. In general, a covered entity or health care provider may disclose protected
health information to a business associate and may allow a business associate to create or
receive protected health information, if the use or disclosure is permitted by the Privacy Rule.
However, in order to disclose protected health information to its business associates, covered
entities must obtain satisfactory assurances through written agreements ("business associate
contracts") that the business associate will appropriately safeguard the information.
The required business associate contractual provisions include (1) limitations on the
business associate's further use and disclosure of protected health information, (2) a
requirement that the business associate must make the protected health information available
for amendment and for audit of disclosures, (3) reporting requirements regarding any improper
use or disclosure of which a business associate becomes aware, (4) the use of appropriate
safeguards to comply with the contract and (5) a requirement that agents or subcontractors who
receive protected health information from the business associate will also comply. The contract
must also (6) require the return or destruction of all protected health information at termination
of the contract, if feasible.
(ii) Disclosures to Business Associates for Marketing
Disclosure of protected health information for marketing purposes is
limited to disclosure to business associates that undertake marketing activities on behalfof the
covered entity. No other disclosure for marketing is permitted. Covered entities may not give
away or sell lists of patients or enrollees without obtaining authorization from each person on
the list. As with any disclosure to a business associate, the covered entity must obtain the
H-9
business associate's agreement to use the protected health information only for the covered
entity's marketing activities. A covered entity may not give protected health information to a
business associate for the business associate's own purposes.
4. FUNDRAISING: 42 C.F.R. § 164.514(f)
In the proposed privacy regulations issued in November 1999, the Department would
have required covered entities to obtain authorizations from an individual in order to use
his/her protected health information for fundraising activities. In the final Privacy Rule, certain
"fundraising" activities on behalf of a covered entity are classified as health care operations3
which would only require general consent. The Department modified the proposed rule after
receiving comments arguing that the proposed rule would have adversely effected charitable
giving. Additionally, it is worth noting that the fundraising provision is not limited to
nonprofit covered entities. HHS considered comments, but ultimately rejected the proposition
stating: "We do not agree that the profit status of a covered entity should determine its
allowable use of protected health information for fundraising. Many for-profit entities provide
the same services and have similar missions to not-for-profit entities. Therefore, the final rule
does not make this distinction." 65 Fed. Reg. 82,718.
(a) Permissible Fundraising Purposes
Under the final Privacy Rule, a covered entity may use or disclose limited
protected health information without an authorization for the sole purpose of raising funds for its
own benefit. Permissible fundraising activities include appeals for money and sponsorship of
events. HHS made clear in commentary that royalties and remittances for the sale of products
of third parties are generally not considered permissible purposes. See 65 Fed. Reg. 82,718.
(b) Only Limited Protected Health Information May Be Used or Disclosed
Covered entities may only use the following protected health information without an
authorization: 1) demographic information4, and 2) dates health care services were provided.
3 "Health care operations means any of the following activities of the covered entity to the
extent that the activities are related to covered functions ... : business management and general
administrative activities of the entity, including, but not limited to ... fundraising for the
benefit of the covered entity." 42 C.F.R. § 164.501.
4 "Demographic information" is not defined in the rule, but HHS noted that it "will generally
include in this context name, address and other contact information, age, gender, and insurance
status. The term does not include any information about the illness or treatment." 65 Fed. Reg.
82,718.
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42 c.F.R. § 164.514(f)(1). Sensitive information such as diagnosis, nature of services, or
treatment and other condition-specific information may not be used or disclosed.
(c) Opt Out Provision
Additionally, fundraising materials must include a description of how the
individual may opt out of receiving any further fundraising communications, and covered
entities are required to honor such requests. Id. § 164.514(f)(2)(ii)-(iii).
(d) Notice of Fundraising Practices
Finally, a covered entity may not take advantage of this provision for fundraising
unless the covered entity's Notice of Privacy Practices clearly states that it may contact the
individual to raise funds. See id. §§ 164.514(f)(2)(i); 164.520(b)(1)(iii)(B).
(e) Disclosures to Business Associates and Institutionally Related Foundations
Covered entities are permitted to disclose this limited protected health
information, consistent with section 164.514(f), to "business associates" for fundraising on its
own behalf and to an "institutionally related foundation." The "institutionally related
foundation" provision was added to "accommodate tax code provisions which may not allow
such foundations to be business associates of their associated covered entity." See 65 Fed. Reg.
82,718. In commentary, HHS explains that:
By "institutionally related foundation," we mean a foundation that
qualifies as a nonprofit charitable foundation under section 501(c)(3) of
the Internal Revenue Code and that has in its charter statement of
charitable purposes an explicit linkage to the covered entity. An
institutionally related foundation may, as explicitly stated in its charter~
support the covered entity as well as other covered entities or health care
providers in its community. For example, a covered hospital may
disclose for fundraising on its own behalf the specified protected health
information to a nonprofit foundation established for the specific purpose
of raising funds for the hospital or to a foundation that has as its mission
the support of the members of a particular hospital chain that includes
the covered hospital. The term does not include an organization with a general
charitable purpose, such as to support research about or to provide
treatment for certain diseases, that may give money to a covered entity,
because its charitable purpose is not specific to the covered entity.
65 Fed. Reg. 82,546 (emphasis added).
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5. ENDNOTE
While the new Privacy Rules are final, HHS has indicated that they make modify or
change certain requirements in the future: "Congress specifically authorized HHS to make
appropriate modifications in the first year after the final rule took effect in order to ensure the
rule could be properly implemented in the real world. We are working as quickly as we can to
identify where modifications are needed and what corrections need to be made so as to give
covered entities as much time as possible to implement the rule." Office of Civil Rights, General
Overview at http://www.hhs.gov/ ocr/hipaa/genoverview.html auly 6, 2001). On July 6,
2001, HHS issued its first set of guidance to answer common questions and clarify confusion
about the final Privacy Rule's provisions. See Office of Civil Rights, Technical Guidance at
http://www.hhs.gov/ocr/hipaa/assist.html auly6, 2001).
Additionally, the National Committee on Vital and Health Statistics ("NCVHS"),
Subcommittee on Privacy and Confidentiality, has held a public hearings to receive information
from the public on implementation of the Privacy Rule's provisions for use and disclosure of
health information for marketing and fundraising. The NCVHS is a statutory public advisory
body to the Secretary of HHS in the area of health data, statistics, and health information policy
and advises the Secretary on the implementation of HIPAA. See 42 U.S.c. § 242k(k).
Transcripts of recent public hearings as well as committee and subcommittee meetings may be
found at www.ncvhs.hhs.gov.
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